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ABSTRACT OF DISSERTATION 
 
 
 
 
Homeodynamic space (HDS) shrinks as vulnerability increases with aging and 
repeated damage to the cells. HDS is lost in alcoholic pancreatitis patients due to 
overconsumption of alcohol, smoking, and high fat diets. Etiologically relevant animal 
models for study of chronic pancreatitis (CP) are needed. In order to begin filling this gap 
a central purpose of this dissertation research was to examine relationships between the 
alcohol and high fat diet (AHF) and pancreatitis with attention to hypersensitivity and 
anxiety-like behaviors. The AHF diet induced pancreatitis described here etiologically 
mimics human risk factors of AHF consumption for advancement to alcoholic CP.  
In this study one group of mice was fed long term with a diet of high fat and 
alcohol for comparison with a group fed normal chow. Mice consumed a liquid diet 
containing 6% alcohol and a high fat supplement ad libitum over a period of five months. 
Each group was evaluated for heat and mechanical hypersensitivity, and histology 
indicative of CP.  
The association of pancreatitis pathology with anxiety has been understudied. 
Anxiety, like pain, is useful as a transient state but when anxiety is prolonged it is termed 
a disorder. Anxiety is often comorbid with pain and depression. Therefore, it is important 
to determine anxiety in mice with CP histology.  
This model was characterized for the interaction of pancreatitis histology, as well 
as persisting pain-, anxiety-, and fear-like behaviors. The AHF diet mice developed 
hypersensitivity, demonstrated anxiety-like behaviors, and showed concurrent histology 
consistent with CP. Nontransgenic mouse models where pancreatitis is induced only by a 
combination of ad libitum liquid food with added alcohol and lard supplementation do 
not currently exist, nor has an in-depth study of anxiety-like behaviors been conducted in 
this mouse model. This dissertation research addresses this knowledge gap.  
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CHAPTER ONE: Introduction and Background 
 
1 INTRODUCTION 
Eight in 100,000 people in the United States are diagnosed annually with painfully 
debilitating chronic pancreatitis (CP) (Yadav and Lowenfels, 2013) and up to 50% of diagnosed 
individuals live up to 20 years with CP (Braganza et al., 2011). CP is described as an 
unresolvable inflammation of the pancreas accompanied by debilitating abdominal pain, nausea, 
vomiting, exocrine and endocrine insufficiency, as well as pathological changes impeding 
normal function that include fibrosis and ductal strictures. Alcoholic chronic pancreatitis is 
irreversible by medical means other than surgical removal of the pancreas, which may be 
effective. Suicide is more common in the pancreatitis patient population (4.9%) than in the 
general population (1.2%) (Nojgaard, 2010).  
The National Commission on Digestive Diseases (NCDD) under the umbrella of the 
National Institute of Diabetes and Digestion and Kidney Diseases (NIDDK), value the 
production of better animal models to further the study of alcoholic pancreatitis (Witt et al., 
2007). Pain-like behaviors in CP animal models are a crucial area to research and have also been 
called for (Reed, 2014) (Refer to Table 1 for definitions of pain terminology). Nontransgenic 
mouse models where pancreatitis is induced only by a combination of ad libitum liquid food with 
added alcohol and lard supplementation do not currently exist, nor has an in-depth study of 
anxiety-like behaviors been conducted in this mouse model. This dissertation research addresses 
this knowledge gap.  
Current rodent models of pancreatitis induced by injected chemical irritants such as 
cerulein or dibutyltin dichloride (DBTC) have proven fruitful for studies of acute pancreatitis. 
Cerulein injections expose the pancreas to supraphysiologic cholecystokinin (CCK) levels, 
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which are not associated with the development of CP in humans, but do produce acute 
pancreatitis-like symptoms in mice (Reed, 2014). Cerulein treatment, a common and 
reproducible method for induction of acute pancreatitis (AP) in mice, causes recurrent damage to 
the pancreas as repeated injections are given, mimicking the cycle of damage to the pancreas by 
repeated human alcohol use (Reed, 2014). DBTC treatment is a less used method as it is not 
highly reproducible, causing acute disease development at a rate of about 33% of treated animals 
in the hands of some investigators (Reed, 2014). In addition, DBTC does not cause CP in 
humans (Reed, 2014). The cerulein and DBTC models, while useful for study of acute 
pancreatitis, do not provide the range of risk factors seen in clinic for CP. 
 
Drinking alcohol can reduce anxiety, relieve stress, and facilitate relaxation in people 
(Gilman et al., 2008). These reasons and others associated with the effects of alcohol can lead to 
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the overuse of alcohol over time and subsequent pancreatic damage (See Table 2 for definition of 
anxiety terminology). Damage to the body from alcohol reduces physiological reserve and 
impacts the ability to maintain health. Physiological reserve is a measure of the ability of an 
organism to adapt physically to stressful stimuli using reserve capacity (Kooman et al., 2013).  
This alcohol-induced damage works in an additive manner to drive losses of physiological 
reserve and health beyond those experienced in normative aging. 
 
Anxiety is a factor in increased life stress and has been shown to accelerate the 
progression and severity of diseases such as cardiovascular disease (CVD) (Krantz and 
McCeney, 2002), HIV (Leserman et al., 2002), and depression (Hammen, 2005). Chronic stress 
alone, while a risk factor in the development of acute pancreatitis (Binker & Binker, 2014), has 
not been shown to cause pancreatitis.  The reduction of anxiety is one possible reason for the 
consumption of more than four alcoholic drinks a day which increases the likelihood of 
developing CP (Kushner et al., 2005, Gilman et al., 2008, Irving et al., 2009). Production of a 
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mouse model that more fully follows etiological risk factors seen in human alcoholic CP 
provides a significant research tool for this disease, giving an etiologically more realistic view of 
the irreversible damage done to the pancreas of the CP patient by continuing alcohol 
overconsumption in the presence of a high fat diet. 
 
 
 
 
Figure 1. A diet high in fat and alcohol damages the pancreas. The interaction of pain-like 
behavior, pancreatitis histology, and anxiety-like behavior. 
 
Etiologically relevant animal models for study of CP are needed. In order to begin filling 
this gap a central purpose of this dissertation research was to examine relationships between the 
AHF diet and pancreatitis with attention to hypersensitivity and anxiety-like behaviors. The 
alcohol and high fat diet induced pancreatitis described here more fully recapitulates human 
etiological risk factors of alcohol and high fat consumption for advancement to pancreatitis. This 
model was characterized for the interaction of the chronic pathological state, persisting pain-like 
behaviors, and anxiety-like behaviors. The research shows that feeding an alcohol and high fat 
diet leads to the development of CP, hypersensitivity, and model anxiety behaviors characterized 
using non-reflexive and reflexive testing. Pancreatitis histology, as well as quantitative and 
qualitative observation of anxiety behaviors, and increased pain-like behaviors indicated loss of 
physiological reserve in the AHF mice. Pain-like and anxiety-like behaviors in the mouse model 
mimic behavior seen in humans with CP. 
 
  
Pancreatitis Histology 
 Anxiety-like Behavior 
Pain-like Behavior High Fat and Alcohol 
 
Damage 
to 
Pancreas 
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2 PURPOSE 
Current models of chemical induction of pancreatitis are well suited for the study of acute 
pancreatitis, however, alcoholic CP models have been called for by those prominent in the field. 
Mouse models showing induction of alcoholic CP in nontransgenic mice using only an ad 
libitum alcohol enriched liquid diet, with supplemental fat are not currently available. The 
purpose of this dissertation research was to develop an alcohol and high fat (AHF) diet induced 
mouse model of CP, while evaluating sensory hypersensitivity, anxiety- and fear-like behaviors 
to provide a reliable and robust mouse model for the study of human alcoholic chronic 
pancreatitis. It should be noted that scientists use animals such as mice to mimic human diseases 
for the purposes of furthering understanding of human disease through animal research. In this 
study a mouse model was developed that shows CP histology, heat and mechanical 
hypersensitivity, and anxiety-like behavior (Figure 1). This mouse model mimics the possible 
physical consequences of human overconsumption of alcohol and high calorie foods.  
3 SPECIFIC AIMS 
3.1 AHF Induced Alcoholic Chronic Pancreatitis Mouse Model 
Specific Aim 1: To characterize pain-like behaviors and pancreatic histology in mice on an 
alcohol and high fat diet versus controls. Hypothesis: Mice on the AHF diet will display 
hyperalgesia and pancreatitis histology. Behaviors and histology were expected to conform to 
that seen in rats that developed CP on the AHF diet. AHF-fed rats develop hyperalgesia, 
increased pancreatic fibrosis, and damage to pancreatic cells and structures defined by further 
histological scoring. Pancreatic histology was assessed using Fast Green with Sirius Red 
counterstain of collagen fibrosis; other cellular morphology was also assessed. Testing included 
mechanical and thermal behavioral assays included the von Frey, hotplate, modified hotplate, 
and the smooth or rough textured mechanical plate. 
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3.2 Anxiety- and Fear-like Behaviors in the AHF Mouse Model 
Specific Aim 2: To characterize anxiety- and fear-like behaviors in mice using non-reflexive 
testing. Hypothesis: Mice on the AHF diet will display higher anxiety- and fear-like 
behaviors than control mice in non-reflexive testing modalities. While rats respond in a 
quantifiable manner to tests such as the hotplate, mice are historically less reliable than rats using 
reflexive testing. For example, in the 50°C hotplate test mice did not show the typical threshold 
markers seen in rats such as licking the hind paw before the cut-off time. While these testing 
methods may appear to measure only sensitivity, sensitivity and anxiety-like/fear-like behaviors 
are interrelated. In this case reflexive testing, in addition to being unreliable with the research 
mice, also would not have allowed the depth of work with anxiety-like and fear-like behaviors. 
Mouse testing methods returning reliable results were developed using non-reflexive methods to 
optimize behavioral testing in this CP mouse model. The following assays were used to measure 
mouse fear-like and anxiety-like behaviors: plus maze, open field, place preference and escape, 
counts of grooming, counts of rearing, and number of uncued freeze events. Non-reflexive 
testing allowed for a more holistic view of the mouse study treatment groups, highlighting 
anxiety-like and fear-like behaviors present in the animal.  
4 BACKGROUND 
4.1 Pain Sensing 
4.1.1 Cutaneous Pain Sensing 
The ability to sense nociceptive stimuli is necessary in order for the organism to remove 
itself from the source of nociceptive stimuli and keep itself from future injury. In this way pain 
behaviors assist an animal in survival. Cutaneous nociception occurs through specialized 
nociceptors that are activated by noxious thermal, mechanical, or chemical stimuli (Woolf, 
2004). Activation of nociceptive receptors or ion channels by noxious stimuli generates an 
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electrical signal. Nociception is composed of transduction, conduction, transmission, and 
perception. The receptor or ion channel transduces the stimuli into electrical current which 
becomes an action potential. Afferent nerves conduct the action potential to the spinal cord from 
the periphery. The action potential causes neurotransmitters to be transmitted from the central 
terminal across the synapse to the dorsal horn neurons (Scholz and Woolf, 2002). The 
nociceptive signal then travels to the brain through ascending pathways such as the 
spinothalamic tract. Perception occurs when the human brain receives the signal and perceives 
pain. An example of cutaneous nociceptive signaling occurs when a person gets a cut on their 
foot and inspects it for damage. 
4.1.2 Fiber Type and Sensing 
Three different fiber types, the Aβ, Aδ, and C fibers carry a wealth of information to the 
brain concerning the environment. Aβ nerve fibers have the largest diameter of the three, are 
well myelinated, and are the fastest to conduct signals. The Aβ fibers carry touch and pressure, 
while Aδ and C fibers carry nociceptive signals. Aδ nerve fibers have a smaller diameter than the 
Aβ, are lightly myelinated, and carry fast pain (described as sharp, lancing, prickly). C fibers 
have the smallest diameter of the three afferent nerve fiber types, with no myelination. C fibers 
carry slow pain (described as dull, burning, poorly localized). 
4.1.3 Acute Pain 
Acute pain results from damage to tissue. Injuries resulting in acute pain are often easily 
localized. A newly received cut on the foot is an injury that would cause acute pain. Acute pain 
resolves before three months’ time as the damaged tissue heals (IASP, 2004, ACPA, 2016). 
Acute pain serves the evolutionally important function of warning of dangerous environments 
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and enabling protection against further damage (Scholz and Woolf, 2002). Unrelieved acute pain 
can develop into chronic pain. 
4.1.4 Peripheral Sensitization 
Acute pain can become chronic pain through the process of sensitization. When there is 
acute tissue damage the environment around the nociceptors changes. Inflammation occurs and 
chemical factors in the ‘inflammatory soup’ like chemokines and cytokines are released (Scholz 
and Woolf, 2002, Woolf, 2004). Some of the factors incite pain while others make nociceptors 
within their reach hypersensitive to stimuli.  
Modulation of receptors or ion channels due to posttranslational changes causes 
sensitization. Chemical factors bind receptors on nociceptors located in the periphery (Scholz 
and Woolf, 2002, Woolf, 2004). Intracellular kinases bind to and activate nociceptive receptors 
and ion channels. Pain hypersensitivity becomes apparent as the threshold of activation due to 
painful stimuli decreases (Woolf, 2004). 
4.1.5 Central Sensitization 
The development of central sensitization is similar to that in peripheral sensitization and 
occurs in the dorsal horn. Posttranslational changes occur in secondary sensor neurons (Scholz 
and Woolf, 2002, Woolf, 2004). In the dorsal horn, neurotransmitter activity by the central 
terminals increases. Synaptic receptors like NMDA are phosphorylated. Hyperalgesia develops 
as synaptic receptors show increased responsiveness to sensory input (Woolf, 2004). 
4.2 Chronic Pain and Health 
4.2.1 Chronic Pain 
Pain that was termed “acute” becomes chronic pain, by definition, after three months 
(IASP, 2004). Chronic pain generally arises from an injury or damage to the body but may have 
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no discernible physical cause. This pain may be present even in the absence of observed damage 
to tissue, for example in people with amputated limbs. Chronic pain can be continuous and 
unrelenting, or it may be intermittent. This type of long-lasting pain may never resolve. People in 
chronic pain experience physical, social, and mental decreases in function (Figure 2) (Fine, 
2011). Pain in this sense encompasses physical pain such as that of CP, as well as mental pain 
manifestations such as anxiety. Chronic uncontrolled pain is exhausting and has great potential to 
decrease quality of life over the long term. Chronic pain can become debilitating (Fine, 2011, 
Mullady et al., 2011, Amann et al., 2013). 
 
In humans physical disease progression and perceived physical pain can both cause and 
be caused by anxiety (Gibson and Helme, 2000, Chiu et al., 2005, Roy-Byrne et al., 2008, Lieb 
and Forsmark, 2009, Harvard, 2010). Perception of pain through a filter of chronic anxiety  
(Harvard, 2010) may increase the overconsumption of alcohol and high fat foods. Long-term 
consumption of high calorie foods and overconsumption of alcohol decreases physiological 
reserve.  
The DNA between humans and mammalian species such as mice is well conserved, as 
are anatomy, and physiology (Dolensek et al., 2015, Nguyen et al., 2015). Nociceptive pathways 
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are similar in mice and in humans, with some minor differences. Characterizing as many factors 
as possible, such as anxiety- and fear-like behaviors, is a common practice in the development of 
a new animal model. 
4.2.2 Homeodynamics & Homeostasis 
Homeodynamics and homeostasis work together in determining the response of the body 
to stimuli. The term homeostasis describes an attempt by the body to continually return to one set 
point, that remains the same, such as temperature, while homeodynamics covers the changes in 
this set-point as the body attempts to adjust to changes affecting its ability to adapt, its 
homeodynamic space (Rattan, 2006). Homeostasis is more like a snapshot in time while 
homeodynamics is more like a longitudinal study as homeodynamics focuses on the entire 
lifespan. Homeodynamic space, a measure of fitness, shrinks during the aging process as cells 
and other biological systems become less adaptable (Rattan, 2008). Successful adaptation leads 
to diminishing of harmful effects on the body and a maintenance the homeodynamic space 
available to the individual. Unsuccessful adaptation leads to shrinking homeodynamic space and 
the inability to counter harmful stimuli as before (Rattan, 2006) (see Table 3). Shrinking 
homeodynamic space has its termination when the organism encounters harmful stimuli it can no 
longer defend against. 
 
 
11 
 
Physiological reserve (PR) is a measure of the ability of an organism to adapt to stressful stimuli 
using reserve capacity (Kooman et al., 2013) and can be used to understand homeodynamics 
(Rattan, 2013, 2014). Homeodynamic space is concerned with damage control, stress response, 
and adaptation (Rattan, 2013, 2014).  These areas of homeodynamic space are impacted by the 
reserve capacity available for use. Body organs in general can lose about 70% of their 
physiological reserve before adequate function is impaired (Bortz, 2002). Impaired function of 
one or more body organs can decrease homeodynamic space. PR decreases over time in 
normative aging (Bortz, 2005). Continued stressful stimuli, in concert with normative aging 
likely decrease PR in an additive fashion over time (Bortz, 2005). 
4.2.3 Homeodynamic Space and Pancreatitis 
The adaptability of an organism’s homeostatic set points to adjust over time with 
fluctuations in the environment is homeodynamics (Rattan, 2008). Shrinking homeodynamic 
space is apparent in the loss of adaptability of the pancreas to repeated insults by 
overconsumption of alcohol and high calorie foods over time. Lost PR in the pancreas in the 
presence of the AHF diet sets the stage for the development of pancreatitis. Alcohol and a high 
fat diet provide a negative stressful stimuli to the cells of the pancreas, which must respond to the 
stimuli and control damage resulting from it. Cells maintaining the function of the pancreas must 
respond to repeated damaging AHF. The continual presence of AHF toxins is likely to 
continually interrupt cellular pancreatic maintenance, leading to pancreatic damage through 
dysregulation of typical pancreatic repair mechanisms. Unhealthy pancreatic parenchyma 
experience a shrinking homeodynamic space, a decreasing ability to adapt to change (Rattan, 
2006). A decrease in homeodynamic space leaves the organism open to greater detrimental 
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effects from stresses than previously experienced as adaptation to the stimuli is impaired. 
Alcoholic chronic pancreatitis could be the consequence of an inability to adapt to stimuli.  
4.2.4 Human Adaption to the Loss of Homeodynamic Space 
There are adaptations to the loss of homeodynamic space that humans can make that 
would be impossible for laboratory mice. Changes in homeodynamic space are diverse in origin 
and nature. For example, in some individuals with unusual genetics, their health will be much 
greater than the norm (Rajpathak et al., 2011). Smoking and even heavy drinking may not 
decrease their physiological reserve (Milman and Barzilai, 2015). Regardless of genetics some 
people may profit from a family or culture that is familiar with the needs of those in old age and 
can extend the lived years using family or cultural methods (checking in on someone, bringing 
meals, having the older person/couple move in with children, other techniques such as providing 
excellent paid healthcare to an older person in a nursing home).  
There are indications that longevity is genetic and can be inherited (Milman and Barzilai, 
2015). Part of the individual ability of someone to reach much older age may have to do with the 
understanding of the possibility of reaching older age, the changes that come with aging (so less 
ageism within the “tribe”, more understanding), and the needs of the older person for assistance 
and caregiving with each stage of older life, in both the individual (as they saw it growing up), 
and in the family. The average younger individual from a family where grandparents passed 
away early and there were few if any much older people around is less likely to understand older 
age and the changes that come with it than someone surrounded by long-lived family members 
throughout their life. The younger individual from a landscape barren of older people may have 
less ability and understanding of how to help an older person to maintain their homeodynamic 
space or even that they can do such a thing. Note that higher socioeconomic groups tend to live 
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longer (Crimmins, 2011), possibly due to the use of resources commonly available to higher 
socioeconomic groups such as time, financial resources, or social connections to allow better 
care of the older adult. Inequality in education, occupation, and health care accessibility are just a 
few possible causes for decreased life span and health in lower socioeconomic groups (Marmot, 
2015).  
An in depth review of the heterogeneity of aging, the attainment of longevity, and the 
many possible human factors leading to the maintenance of human homeodynamic space is 
beyond the scope of this dissertation. A detailed discussion of possible human social 
interventions would also be out of place in this description of research leading to the successful 
development and characterization of a mouse model of chronic pancreatitis.  
4.3 Social Aspects of Alcoholic Chronic Pancreatitis  
A number of factors can combine to contribute to loss of physiological reserve within the 
human body as well as within the pancreas itself. Often two or more of these endogenous or 
exogenous factors interact to provide “two hits” that allow pancreatitis to develop: inherited 
disease mutations, a diet high in fat, the overconsumption of alcohol, smoking, and chronic 
stress/anxiety.  
One way to help add more years to life and more life to years is to better understand the 
complexity of how disease affects people, and study how to cure or at least temper the symptoms 
of painful diseases such as CP. There are indicators (Takano et al., 1992) that stress and anxiety 
can speed progression or severity of CP. There are also indications that counseling and other 
interventions that pay attention to the whole person, especially their mental state, can help 
decrease healthcare utilization (Madan et al., 2013).  
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In 2004, pancreatitis cost the United States $373.3 million in direct and indirect costs 
(Everhart and Ruhl, 2009). There are three main types of direct medical cost: doctor visits, 
hospitalization, and diagnostic tests (Sherman et al., 2001). Indirect costs include out-of-pocket 
expenses related to patient care, such as loss of wages due to illness or sacrifice of caregiver 
time; payments for prescription drugs; and copayments for healthcare (Houts et al., 1984, 
Sherman et al., 2001).  
There are no causal cures for CP; behavioral modification can help, especially in acute 
pancreatitis. Madan (2013) shows that paying attention to the mental state of the pancreatitis 
patient is critical to controlling the disease. A possible method to control the progression of 
human AP and possibly CP could be to control the anxiety that Takano et al. (1992) has shown 
to speed the progression of CP in rats. A broader social change with cessation of blaming the 
sick, and with the provision of mental health services for those in need, with reversal of the 
stigma that can be attached to consulting a mental health professional could provide what is 
needed to help those at risk for developing, as well as those already suffering with pancreatitis.  
4.4 Chronic Pancreatitis 
CP is described as an unresolvable inflammation of the pancreas accompanied by 
debilitating abdominal pain, nausea, vomiting, exocrine and endocrine insufficiency, as well as 
pathological changes impeding normal function that include fibrosis and ductal strictures. 
4.4.1 Classification of Pancreatitis by Etiology 
Pancreatitis is classified according to the TIGAR-O system: toxic, idiopathic, genetic, 
autoimmune, recurrent acute, and obstructive (Kloppel, 2007, Nitsche et al., 2011). The 
dissertation research is specifically focused on the development of alcoholic chronic pancreatitis 
which falls within the toxic, more specifically a chronic toxic etiology.  
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Toxic sources for the development of pancreatitis include alcohol, exposure to cigarette 
smoke, hypercalcemia (hyperparathyroidism), hyperlipidemia (rare and controversial), chronic 
renal failure, medication such as phenacetin, and toxins such as organotin compounds (such as 
DBTC) (Etemad and Whitcomb, 2001).  
An idiopathic disease has no known cause and this is true of idiopathic pancreatitis. The 
classification of pancreatitis as idiopathic is decreasing as an increasing number of genetic 
causes of pancreatitis are determined (Witt, 2007). Idiopathic pancreatitis is classified as Early 
Onset, Late Onset, Tropical, or Other (Etemad and Whitcomb, 2001). Early Onset idiopathic 
pancreatitis is diagnosed around 23 years, while Late Onset occurs around 62 years of age 
(Mullhaupt et al., 2005). Tropical pancreatitis is typically diagnosed around 22 years, progresses 
quickly, and shows extensive pancreatic damage (Balakrishnan et al., 2006).   
A number of genetic causes of pancreatitis have been identified with more being 
discovered regularly. Early known genetic mutations predisposing people to pancreatitis were 
limited for a time to the cystic fibrosis transmembrane conductance regulator (CFTR), serine 
protease 1 (PRSS1), and the serine protease inhibitor, Kazal type 1 (SPINK1) mutations (Witt et 
al., 2007). Genetic pancreatitis symptoms can start as early as age 10 (Mullhaupt et al., 2005). 
They can be autosomal dominant or autosomal recessive (Etemad and Whitcomb, 2001). CFTR 
regulates bicarbonate secretion by the ducts and may be responsible for defective transport of 
inactive enzymes (Witt et al., 2006, Witt et al., 2007). There are a variety of PRSS1 mutations 
conferring gain of function, these can inhibit autolysis or increase auto-activation of trypsinogen 
(Teich et al., 2006, Witt et al., 2006). The SPINK1 mutation causes a loss in function in the 
inhibition of trypsinogen activation within the pancreas (Witt et al., 2007). CLDN2, as well as 
the following are more recent additions to the list of genetic mutations: CASR, CTRC, CTSB, 
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CTGI. Many genetic mutations have to do with changes in the inhibition and inactivation of the 
trypsin enzyme. 
More heavy drinking men than women are afflicted with alcoholic CP. This is likely due 
in part to the influence of recently described X-linked polymorphism rs12688220, located near 
the human claudin-2 gene (Whitcomb et al., 2012). The rs12688220 single nucleotide 
polymorphism (SNP) is found in 50% of males with CP, but only 26% of males in the general 
population (MUSC Health, 2013). The increased percentage of CP in males with the rs12688220 
SNP indicates that this SNP is a risk factor for CP.  
Autoimmune pancreatitis (AIP) occurs when the body’s immune system attacks its own 
pancreas. AIP responds to steroids (Kamisawa et al., 2008). The average age of diagnosis for 
AIP is 59 years old (Okazaki, 2001).  
Recurrent Acute Pancreatitis (RAP) refers to pancreatitis that resolves then recurs. RAP 
causes reversible damage to the pancreas over a period of time. Doctors recommend abstinence 
from alcohol and quitting smoking to decrease the chances of recurrence. Users of Type 2 
diabetes medications, sitagliptin and exenatide increase the risk of developing RAP by 6 times 
(Yadav and Lowenfels, 2013). Gallstones, for which age and female gender are a risk factor, are 
a common cause of acute pancreatitis (Yadav and Lowenfels, 2013). 
Obstructive pancreatitis can occur for a number of reasons, one of which is tumorous 
obstruction of ducts (Kloppel, 2007).  
4.4.2 Physiology of Chronic Pancreatitis 
The pancreas is composed of both exocrine and endocrine cells. Pancreatic exocrine cells 
excrete digestive enzymes, while endocrine cells (known as Islets of Langerhans) serve 
homeostasis as they release glucagon and insulin hormones as needed into the bloodstream to 
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control blood sugar levels. The exocrine cells are known as acinar cells and are arranged around 
ducts through which unactivated digestive juices flow to the duodenum, become activated 
(trypsinogen becomes trypsin), and assist in the digestion of food. CP is characterized by 
unresolvable and painful inflammation of the pancreas as pancreatic enzymes such as 
trypsinogen, activate while still within the pancreas, leading to autodigestion of the pancreas 
(Hirota et al., 2006). The flow of unactivated digestive enzymes to the duodenum significantly 
decreases in pancreatitis as blocked ducts become unable to conduct enzymes out of the pancreas 
(Hirota et al., 2006). Autodigestion of the pancreas by prematurely activated trypsin causes 
collagen scar tissue to form; i.e. increase in pancreatic stellate cell (PSC) proliferation and 
fibrosis. This further decreases the function of the structures and cells within the pancreas. 
Histologically, an increase in fibrosis and activated PSC’s indicates the chronic state of 
pancreatitis (Ammann and Mullhaupt, 2007, Erkan et al., 2009, Zhang et al., 2013, McIlwrath 
and Westlund, 2015, Zhang et al., 2015). Pancreatic insufficiency begins to affect both the 
exocrine and endocrine functions as CP progresses (Forsmark, 2013). The above is a general 
non-species specific recounting of the events that occur during the onset of chronic pancreatitis. 
It is necessary to contrast both mouse and human pancreatic anatomy, and exocrine 
function. The endocrine function of the pancreas has not been shown to cause the development 
of alcoholic CP and will not be covered. The human pancreas is composed of a head, a body, and 
a tail. While it has distinct lobes, it is a solid and well-defined organ (Dolensek et al., 2015).  The 
acinar cell is part of an acinus, which is responsible for moving secretions of the acinar cells into 
larger ducts. Pancreatic ducts drain from the acinus into larger ducts then finally into the one 
main pancreatic duct, which runs the length of the organ in humans (Dolensek et al., 2015). The 
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bile duct and the main pancreatic duct empty into the duodenum at the ampulla of Vater 
(Dolensek et al., 2015). The main duct in humans is adjacent to the bile duct. 
The mouse pancreas is composed of three lobes: the splenic lobe (SL) (Watanabe et al., 
1995), the duodenal lobe (DL), and the gastric lobe (GL) (Liu et al., 2010). The pancreas of the 
mouse is a solid as opposed to a hollow organ but is diffusely distributed in the mesentery of the 
small intestine (Bunnag et al., 1963). Each lobe of the three-lobed mouse pancreas has a main 
duct (splenic, duodenal, and gastric). The gastric duct drains into the splenic duct, which meets 
the bile duct, then empties into the ampulla of Vater. The duodenal duct separately meets the bile 
duct which empties at the duodenum into the ampulla of Vater (Lacy and Kostianovsky, 1967). 
The main ducts in the mouse pancreas join the bile duct before reaching the duodenum. 
A comparison of human and mouse pancreatic anatomy, exocrine function, and tissue 
level similarities is necessary. The SL is like the human pancreatic body and tail (Watanabe et 
al., 1995), the DL is like the head, and the GL is like the pyramidal process in the pancreas of 
humans (Dolensek et al., 2015). The mouse pancreas has three “main” ducts, likely an adaptation 
to its more diffuse nature. The presence of more ducts to drain the mouse pancreas would be 
analogous to the larger ducts leading to the main duct in humans. Acinus are present in both 
human and mouse pancreas and serve the same general purpose, to provide enzymes to digest 
chyme. That human and mouse ducts are differently married to their respective pancreatic areas 
is likely not a critical factor in the development of CP because the arrangement of ducts in the 
mouse pancreas would be analogous to that in the human pancreas and would be expected to 
affect the end use of the pancreatic secretions in the same general way in both species. The 
development of CP begins when harmful stimuli affect the acinar cell. Dolensek (2015) in a 
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paper describing the similarities and differences inherent in mouse and human pancreas, 
mentions little difference between the individual acinar cells and the acinus.  
In summary, while there are differences between the mouse and human pancreas, except 
for the few key differences notes below, they would be expected to have little impact on the 
development of CP and the use of this AHF diet to induce CP.  The main difference between the 
AHF diet in humans versus mice follows: the distinctiveness and small surface area to volume 
ratio of the human pancreas versus the diffuse nature and large mass to volume ratio of mouse 
pancreas to mouse body could lead to faster alcohol exposure in the pancreas in mice relative to 
humans. Neuropathic changes such as the sprouting of nerves with continued damage to the 
pancreas would be expected to increase pancreatic nociceptive capability at a faster rate in the 
mouse. The differences mentioned in this paragraph are more likely to affect speed of 
progression of CP than the development of CP. 
The factors below combine to make a compelling use for mouse models that mimic 
human diseases, but do not fully recapitulate them (Malina, 2010, Dolensek et al., 2015, Nguyen 
et al., 2015). Mouse models allow for research that would be unethical in humans (Nguyen et al., 
2015). Comprehensive understanding and tools for modification of the mouse genetic code make 
the mouse useful as a genetic tool (Nguyen et al., 2015). Mice conveniently require relatively 
low maintenance, reproduce at a high rate, and have a short life-cycle (Malina, 2010, Nguyen et 
al., 2015). Mice are omnivorous and can consume diets as similar in composition to human diets 
as possible (Nguyen et al., 2015). Herbivorous animals are less likely to consume animal fat than 
are mice, making them less useful as AHF research model animals. Inbred mouse models 
provide a homogenous genetic background (Nguyen et al., 2015). While mouse/human genetic 
conservation is generally high (Malina, 2010, Nguyen et al., 2015), there are genetic differences 
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between the species, they are genetically similar but not exactly similar. In a similar manner, 
mouse anatomy and physiology is similar to humans but not exact (Nguyen et al., 2015). 
Laboratory conditions allow control of many factors in the mouse (Nguyen et al., 2015). Humans 
cannot be subjected to the same kind of control over diet and environment as mice can and this 
introduces additional variables into human experiments due to human heterogeneity.   
4.4.3 Epidemiology of Chronic Pancreatitis          
Alcoholic chronic pancreatitis is described as an unresolvable inflammation of the 
pancreas accompanied by debilitating abdominal pain, nausea, vomiting, exocrine and endocrine 
insufficiency, as well as pathological changes impeding normal function that include fibrosis and 
ductal strictures.  
Alcohol overconsumption increases the risk of developing alcoholic CP, as does smoking. 
Alcohol has a 40% attributable risk in the development of CP (Frulloni et al., 2009), with 70% of 
those with CP showing alcoholic etiology (Martinez et al., 2004, Siech et al., 2009). Smokers 
have two to three times as much chance of developing CP as do nonsmokers (Yadav and 
Lowenfels, 2013).  
The following suggests that a high fat diet increases the amount of fibrosis present in the 
pancreas. A high fat diet has been shown in rats to activate pancreatic stellate cells (PSC) and 
cause an increase in alpha smooth muscle actin (α-SMA, a marker for fibrosis) in the pancreas 
(Zhang et al., 2008, Zhang et al., 2015). Collagen is closely associated with α-SMA in CP (Haber 
et al., 1999). Fibrosis is composed of collagenous material like collagen 1.  
Humans who eat a high fat diet are more likely to develop CP. Indeed, the contributions 
of a high fat diet in humans are expected to provide one of the two “hits” needed to develop 
alcoholic CP. Note that the obese have twice the risk of developing CP (Martinez et al., 2004).  
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Kentucky is ninth in the nation for obesity, with an obesity rate of 36% in 45-64 year olds in 
Kentucky (RWJF, 2013). Kentucky has a high percentage of obese people who could be at risk 
of developing chronic pancreatitis.  
Scientists can use a variety of models, including models that use from biomolecules up to 
the whole animal to tease out the mechanisms, signaling pathways, and other characteristics of a 
disease such as chronic pancreatitis. These animal models are used to mimic human disease. As a 
common practice, scientists compare data collected from different mammalian models as well as 
humans in the same manuscript. Because rat, mouse, and human genomes are genetically 
conserved, mentioning how CP has been shown to work in rats, while adding how CP has been 
shown to or is expected to work in humans, gives justification to the production of a mouse 
model of CP using the AHF diet. 
4.4.4 Risk Factors 
The development of CP in humans has multiple possible contributing risk factors. 
Though many non-physical factors could contribute to the development of CP the risk factors of 
alcohol and obesity are the focus of this research. One risk factor is the sensitizing effect of 
alcohol on the pancreatic cells (Forsmark, 2013). Alcohol combines with other factors such as a 
high fat diet to cause pancreatic damage. People with a history of drinking heavily have four 
times the risk of developing CP than those that do not (Yadav et al., 2007b). Note that as a 
person ages their tolerance for alcohol declines so that the same amount of alcohol they used to 
drink becomes an unhealthy amount over time (NIA, 2011). High alcohol intake has also been 
associated with hypertriglyceridemia, another risk factor for pancreatitis (Klop et al., 2013).  
More heavy drinking men than women develop alcoholic CP (Lankisch et al., 2002, 
Yadav et al., 2011a). This is likely due to the influence of recently described X-linked 
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polymorphism rs12688220, located near the claudin-2 gene (Whitcomb et al., 2012). The 
rs12688220 single nucleotide polymorphism (SNP) is found in 50% of males with CP, but only 
26% of males in the general population (MUSC Health, 2013). The increased percentage of CP 
in males with the rs12688220 SNP indicates that this SNP is a risk factor for CP. Other 
mutations result in CP, these are: CFTR, SPINK1, and PRSS1 (Witt et al., 2007) as well as 
CTRC, and GGT1. 
In 2004, pancreatitis cost the United States $373.3 million in direct and indirect costs 
(Everhart and Ruhl, 2009). There are three main types of direct medical cost: doctor visits, 
hospitalization, and diagnostic tests (Sherman et al., 2001). Indirect costs include out-of-pocket 
expenses related to patient care, such as loss of wages due to illness or sacrifice of caregiver 
time; payments for prescription drugs; and copayments for healthcare (Houts et al., 1984, 
Sherman et al., 2001).  
4.4.5 The Disposable Soma Theory  
The theory of disposable soma, proposed by Medawar (1952), is relevant to the common 
diagnosis period of CP at 40 to 50 years of age (Whitcomb et al., 2008).  The theory of 
disposable soma suggests that natural selection is focused on maintaining health through the 
reproductive years in order to maximize the number of offspring.  Once the bulk of reproduction 
is complete the body, the soma, is disposable, and natural genetic selection for fitness is neutral 
to the gradual loss of physiological reserve over time in the post reproductive organism 
(Kirkwood and Holliday, 1979, Charlesworth, 2000, Kirkwood, 2005). Natural selection includes 
genetic selection for high health during reproductive years. Human reproduction was historically 
complete or nearly complete by the mid 40’s during which alcoholic chronic pancreatitis is 
diagnosed. There was no reason to select for those without genetics that predisposed to CP 
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because the development of CP did not interfere with reproductive fitness. Note that across 
history survival to the mid 40’s was not assured.  
 According to the disposable soma theory once reproduction is completed body systems 
and individual organs such as the pancreas begin to lose PR. With age the human pancreas shows 
fatty infiltration, some fibrosis, and a widening of the main pancreatic duct (Glaser and 
Stienecker, 2000, Wei, 2000). While the aging pancreas shows a gradual loss of physiological 
reserve over time, a pancreas with increased continuous damage due to etiologically determined 
factors in the development of CP such as alcohol would be expected to display much higher 
parenchymal fibrosis, along with other indicators of damage such as calcifications (Etemad and 
Whitcomb, 2001). 
4.4.6 The Theory of Waste Accumulation  
 The theory of waste accumulation (Kirkwood, 1997) is apparent in the discussion of 
chronic pancreatitis. In normal function the quiescent pancreatic stellate cells (PSC), vitamin-A 
containing star-shaped support cells, lay down extracellular matrix (ECM) which is later 
removed. This process heals damage to the pancreas.  
 Damage to the pancreas activates the normally quiescent PSC to repair damage (Apte et 
al., 2012, Means, 2013). The Vitamin-A droplet of quiescent PSC’s is lost with activation as the 
PSC take on a myofibroblast-like appearance (Bachem et al., 1998, Apte et al., 2012). In CP the 
activated PSC synthesize and deposit excessive ECM to resolve damage however, surplus ECM 
is not degraded (Apte et al., 2012). Dysregulation of ECM removal by the PSC leads to the 
accumulation of ECM. ECM presents as fibrosis and interferes with pancreatic function. The 
buildup of ECM decreases the physiological reserve of the pancreas, lowering its functional 
ability. Over time, this decreases homeodynamic space. 
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4.4.7 Development of Pain in Alcoholic Chronic Pancreatitis 
The pain report in pancreatitis patients increases over time as the disease progresses from 
acute pancreatitis to CP. Acute pancreatitis pain tends to subside for a period of time as acute 
pancreatitis is indicative of reversible damage to the pancreas. AP risk of progression to 
alcoholic chronic pancreatitis depends on changes in drinking habits following the initial attack 
(Takeyama 2009). Takeyama et al. (2009) found that abstainers progressed to alcoholic CP in 
14% of cases while those who continued habits of heavy drinking after AP diagnoses went on to 
develop alcoholic CP in 41% of cases. The pattern of developing AP and progressing to CP is 
important in pain development in CP because pain in AP is acute in nature while pain in CP is 
chronic.  CP symptoms can include abdominal pain radiating to the back, worsening of pain after 
eating, especially after fatty meals, exocrine and endocrine insufficiency, and the presence of 
anxiety (Walsh et al., 2012, Poulsen et al., 2013).  
CP is associated with irreversible damage to the pancreas as well as the presence of 
fibrosis (Poulsen et al., 2013). Pancreatic tissue becomes fibrotic reducing function. Eventually 
blood sugar regulation and food digestion are affected. CP pain remains a possibility at any time 
for someone with CP. The pain of CP increases when neuropathy is present (Poulsen et al., 
2013). Neuropathy includes sprouting of the intrapancreatic nerves, and activation of immune 
cells (Poulsen et al., 2013). 
Nociceptive stimuli are sensed by a variety of nerve cells that can detect nociceptive 
stimuli or injury and transduce them into electric signals (Pasricha, 2012, Poulsen et al., 2013). 
Primary afferent nerves have their cell bodies in the dorsal root ganglia (DRG) next to the spinal 
cord (Poulsen et al., 2013). These nociceptors begin as nerve endings in a particular tissue and 
insert their central endings into the dorsal horn of the spinal cord. The peripheral nerve receptors 
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detect physical or chemical stimuli. An action potential can move through the nerve to the dorsal 
horn of the spinal cord. Neurotransmitters are released and secondary transmission neuron axons 
carry the pain signals to the brain. The sensation of pain is formed in humans from this stimulus.  
Prolonged peripheral nerve stimulation, for example from a continuing injury, can lead to 
the sensitization of nociceptors by neurotransmitters. Nociceptor plasticity of this kind can result 
in a reduction in activation threshold, an increased response to pain stimuli, and can give the 
impression of spontaneous activity (Basbaum et al., 2009, Poulsen et al., 2013). Sensitization of 
peripheral nerves in this manner is called peripheral sensitization. 
Peripheral sensitization can also sensitize central pain transmitting neurons in the dorsal 
horn (Basbaum et al., 2009, Poulsen et al., 2013). Central sensitization can accompany strong 
and/or continuous noxious peripheral stimuli, and tissue or nerve damage (Poulsen et al., 2013). 
The overarching effect of central sensitization is felt as pain in humans. This pain no longer 
reflects the actual presence, intensity, or duration of pain emanating from the periphery (Poulsen 
et al., 2013). 
CP patients show increases in neurotransmitters associated with pain sensation such as 
calcitonin gene regulatory product (CGRP), Substance P (SP), nerve growth factor (NGF), brain-
derived neurotropic factor (BDNF), and proinflammatory cytokines (Basbaum et al., 2009, 
Poulsen et al., 2013). Certain neurotransmitters activate the nerves innervating the inflamed 
pancreas and cause excitation of the secondary transmission neurons. Antagonizing each of these 
neurotransmitters pharmacologically decreased pain in rats with chronic pain (Basbaum et al., 
2009).  
Afferent nerves carry nociceptive signals to the central nervous system following the 
detection of stimuli from nociceptors. One such nociceptor neuron channel of particular interest 
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due to its contribution to pain in CP is the transient receptor potential cation channel subfamily V 
member 4 (TRPV4). The TRPV4 channel senses mechanical pressure, as well as heat, and is 
activated by alcohol metabolites (Ceppa et al., 2010, Everaerts et al., 2010).  
One theory as to the development of CP is that mechanical pressure can increase in the 
damaged pancreas due to clogged ducts as alcohol decreases the solubility of proteins in the 
ductal space and increases fibrosis, leading to plugging of the ducts and the subsequent 
autodigestion of the pancreas (Masamune et al., 2009, Braganza et al., 2011). The literature 
shows no agreed upon correlation between “general” pancreatic fibrosis and the amount of 
mechanical pressure due to plugged ducts. Fibrosis does not show a specific development or 
progression through a specific area in the pancreas such as the head, body, or tail. However, the 
Necrosis/Fibrosis hypothesis asserts that focal areas of damage caused by insult to the pancreas 
become necrotic and then are replaced with fibrosis (Witt et al., 2007).  
The nerves of the mouse pancreas associate with blood vessels of different sizes. Post-
ganglionic sympathetic nerve fibers, for example, are associated with the acini and capillaries 
(Lindsay et al., 2006). The peri-vascular mesenteric nerve plexus associates along the superior 
mesenteric artery as they pass through the pancreas (Lindsay et al., 2006). The largest blood 
vessels were found in association with A-delta and A-beta fibers (Lawson and Waddell, 1991, 
Lindsay et al., 2006). CGRP positive sensory fibers enter the pancreas by the splanchnic nerve 
through the mesenteric and celiac ganglion in the rat (Su et al., 1987). CGRP-positive small 
unmyelinated and medium diameter thinly myelinated sensory nerve fibers are seen in 
association with large and medium sized blood vessels as well as the islets (Lindsay et al., 2006).  
Lindsay et. al (2006) found in the mouse that sensory nerves containing CGRP are 
characterized as A-delta or C-fibers. CGRP-positive sensory fibers (A-delta or C-fibers) are 
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located at highest densities in the pancreatic head, next highest densities in the body, then the 
lowest density in the tail of the pancreas (Lindsay et al., 2006). Examples of nociceptive 
receptors found on A-delta or C-fibers include bradykinin receptors (Ma, 2001), tyrosine kinase 
A (TrkA) receptors (Averill et al., 1995), transient receptor potential vanilloid-1 (Michael and 
Priestley, 1999, Hwang et al., 2005), proteinase-activated receptor 2 (Hoogerwerf et al., 2001), 
transient receptor potential vanilloid-4 (Zhang et al., 2015). Nociceptors such as these mediate 
acute pancreatic pain (Hoogerwerf et al., 2001, Wang and Westlund, 2001, Winston et al., 2003, 
Hoogerwerf et al., 2004).  
As a visceral organ the pancreas displays little pain signaling under non-pathological 
conditions. Damage to the pancreas results in pain signaling. The TRPV4 channel located in the 
pancreatic nerves (Ceppa et al., 2010) is becoming well known as a source of pain signaling in 
pathological conditions. Damage to pancreatic parenchyma by alcohol and fat has been shown to 
increase the TRPV4 in the pancreas (Zhang et al., 2013, Zhang et al., 2015) in a rat AHF model. 
Pancreatic afferent nerves connect to second order neurons in the spinal cord that are sensitized 
by the continuous presence of alcohol and other substances (Forsmark, 2013). Increased TRPV4 
is thought to increase pain signaling in human CP patients.   
Alcohol and fat contribute to damage and nociceptive signaling of the pancreas. For 
example, Zhang (2013) demonstrated that the pancreatic stellate cells isolated from the pancreas 
of rats fed the AHF diet are activated by alcohol. Increased numbers of TRPV4 are the likely 
cause for increased pain signaling as they are activated by alcohol and fat (Ceppa et al., 2010, 
Zhang et al., 2013, Zhang et al., 2015). TRPV1 and P2X7 channels are also activated in 
pancreatitis (Kunzli et al., 2007, Ceppa et al., 2010, Schwartz et al., 2013). Alcohol damages the 
pancreas, activating neurogenic inflammation (NI), and causing release of Substance P (SP) 
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(Ceppa et al., 2010). SP causes the release of proinflammatory mediators to occur (Vera-
Portocarrero and Westlund, 2005).  
As damaging alcohol-related conditions in the pancreas continue, fibrosis and tissue 
atrophy within the pancreas increases (Forsmark, 2013). The pancreas processes ethanol with 
fatty acids (FA) from high fat foods, to produce fatty acid ethyl esters (FAEE) (Siech et al., 
2009). FAEE, as well as reactive oxygen species (ROS) produced from the ethanol, damage the 
pancreatic cells. The pancreatic stellate cells eventually form fibrosis that interferes with 
pancreatic functions (Masamune et al., 2009) as they attempt to repair damaged pancreatic cells 
(Siech et al., 2009). 
Pancreatic histopathology of mice fed the alcohol and high fat diet showed morphological 
disruption common to CP: atrophy, fibrosis, diffuse nuclear material and poor cellular 
architecture. Fibrosis interferes with and eventually halts the functions of the pancreas. Cellular 
architecture refers to the orderly arrangement of acinar cells into an acinus with duct. As 
pancreatic functions slow, comorbidities such as diabetes mellitus type 3c and poor nutrition 
occur (Cui and Andersen, 2011, Ewald and Bretzel, 2013). 
Loss of exocrine function can cause a specific form of diabetes called diabetes mellitus 
type 3c (T3cDM). T3cDM refers to loss of function in the endocrine pancreas due to pancreatic 
damage caused by either acute or chronic pancreatitis of any type (Ewald and Bretzel, 2013). 
Diagnosis of T3cDM is hampered by the prevalence of type 2 diabetes mellitus (T2DM) which is 
prevalent in the population at 8% (Gudipaty, 2015). A study by Ewald showed that 10% of 
patients at a German academic clinic had T3cDM, but had been classified as T2DM (Ewald et 
al., 2012). Diagnostic criteria for T3cDM include but are not limited to: exocrine pancreatic 
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insufficiency, positive pancreatitis imaging, and the absence of type 1 diabetes mellitus (Ewald 
and Bretzel, 2013). 
4.4.8 The Epidemiology of Alcoholism 
The development of alcoholic CP is impacted by the genetics and behaviors of those who 
are doing the drinking, how much they drink, as well as their pattern of drinking. Just under 65% 
of American adults drink alcohol (NCHS, 2013). 30% of people who drink in America are heavy 
drinkers (NIAAA, 2010). See next paragraph for the definition of light, moderate and heavy 
drinking categories. Hasin et al. (2007) determined that 17% of men and 8% of women will at 
some time in their lives meet the criteria for alcohol abuse. Drinking, when begun at an early age, 
can lead to the development of alcohol dependence (Hingson, 2009). The number of current 
drinkers in the American population peaks between 25-44 years, with a steady decline as age 
increases (NCHS, 2013).  
The pattern of drinking adopted is used to determine whether someone is a heavy, 
moderate, or light drinker (NIAAA, 2010). Light drinkers drink less than 3 drinks a week on 
average (NIAAA, 2010). Low risk drinking levels are understood as ≤4 drinks a day and/or ≤ 14 
drinks a week for men, and ≤3 drinks a day and/or  ≤7 drinks a week for women (NIAAA, 2010) 
and those over 65 (NIA, 2011). High risk drinkers consume greater than 4, or 3 drinks a day 
and/or may have greater than 14, or seven drinks a week (depending on sex) (NIAAA, 2010). 
“Binge drinking”, a process of drinking greater than 5 drinks in one day, peaks at between 18-24 
years, and then falls steadily to age 64 (NCHS, 2013). A steep drop in binge drinking occurs at 
65 years, and also at 75 years and older (NCHS, 2013). Binge drinking is a particular risk for 
pancreatitis (Irving et al., 2009). Heavy drinking that occurs at younger ages damages the 
pancreas, decreasing physiological reserve, but may not impact perceived health until later in life. 
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Blood alcohol concentration (BAC) is a measure of alcohol concentration in the blood. 
The BAC changes depending on how much and what type of alcohol has been consumed over a 
period of time (Cox et al., 1985, Fisher et al., 1987). At the low end of the range (BAC=0.021) 
humans may exhibit slight impairment (NHTSA, 2005). A BAC of 0.08 in a human is considered 
legally intoxicated (NHTSA, 2005). For example, a BAC of 0.086 would result in a loss of 
balance and reaction time in humans (NHTSA, 2005). Please see page 89 for more information. 
4.4.9 The Epidemiology of a High Fat Diet 
Rats fed the AHF diet develop chronic pancreatitis (Zhang et al., 2014, McIlwrath and 
Westlund, 2015, Zhang et al., 2015). The particular type of fat needed to induce pancreatitis, 
beyond that used in the literature, is beyond the scope of this dissertation. Cardiovascular 
complications due to obesity from the high fat diet were neither quantitatively nor qualitatively 
observed, nor were they seen in mice used in the research. One reason why the “high fat” part of 
the AHF diet is justified for use in mouse models of CP is due to rats reliably developing CP on 
the AHF diet. Another reason for using the “high fat” part of the AHF diet is that obese humans 
are at increased risk of developing CP (Sadr-Azodi et al., 2013). A consideration for the use of 
the “high fat” part of the diet is that AP can be brought on by high fat meals (Thomas et al., 
2012). Recall that AP can progress to CP, especially in the presence of alcohol (Thomas et al., 
2012).  
Obesity (BMI >30) (NCHS, 2013) is likely to occur upon consumption of a high fat diet. 
Americans on average, consume more calories than necessary. The American diet has increased 
per capita fat consumption from 120 g in 1909 to 170 g in 2000 (Gerrior, 2004). This rise in per 
capita fat consumption (Gerrior, 2004) is a likely contributor to the current obesity epidemic.  
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Excess calories can be consumed in fast food, foods consumed during sports events, at 
celebrations, and on holidays, among others. Sugared drinks including soda and coffee contain a 
“hidden” source of calories as people may not realize and track the number of calories present in 
their drinks. 50% of Americans consume at least one sugared drink per day (Ogden, 2011, 
Harvard, 2012).  
One possible reason for the overconsumption of calories in any form is a lack of 
knowledge or understanding of portion sizes. Nutrition labels are present on consumables and 
inform on a number of variables including calories per serving, serving size, as well as amount of 
sugar, protein, and other characteristics of the consumable (CDC, 2015b). Excess calories are 
converted to fat by the body, contributing to obesity.  
Obesity doubles the risk of developing CP (Sadr-Azodi et al., 2013) and can occur due to 
consuming more calories than are expended. More than 27% of Americans are currently obese; 
nearly 35% of non-obese Americans are overweight (BMI 25-30) (NCHS, 2013). The percent of 
obese Americans increases in a stepwise fashion from about 17% at 18 to 32% at 64 years 
(NCHS, 2013). Thereafter obesity declines from about 31% between 65-74 years and to a low of 
about 18% in those older than 74 years (NCHS, 2013).  
4.4.10 Anxiety and Pancreatitis Histology 
The association of pancreatitis histology with anxiety has been understudied. Anxiety, 
like pain, is useful as a transient state but when anxiety is prolonged it is termed a disorder. 
Anxiety can cause a mouse to pay better attention to its surroundings so it can avoid a possible 
predator. As a transient state, anxiety allowing escape from a predator is useful. Long-term 
increased anxiety, however, could interfere with daily survival, for example, a mouse regularly 
too anxious to eat a full meal due to continually checking for predators. Steimer (2002) 
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suggested that anxiety is defined as “a psychological, physiological, and behavioral state induced 
in animals and humans by a threat to well-being or survival, either actual or potential.” 
Overarching anxiety of this kind in humans is characterized by “a marked, persistent, & 
excessive or unreasonable fear” (DSM-4) that interferes with normal life (Roy-Byrne et al., 
2008). Anxiety is often comorbid with pain and depression (Kroenke et al., 2013). Therefore, it 
is important to determine anxiety in mice with CP histology.  
4.4.11 Summary 
Etiologically relevant animal models for study of CP are needed. In order to begin filling 
this gap a central purpose of this dissertation research was to examine relationships between the 
AHF diet and pancreatitis with attention to hypersensitivity and anxiety-like behaviors. The 
alcohol and high fat diet induced pancreatitis described here mimics human etiological risk 
factors of alcohol and high fat consumption for advancement to alcoholic chronic pancreatitis. 
This model was characterized for the interaction of the chronic pathological state, persisting 
pain-, anxiety-, and fear-like behaviors. 
 Pancreatitis is painful, and decreasing pain in this patient population is a priority. Current 
medications for the chronic pain of chronic pancreatitis do not relieve the pain long-term. 
Initially the pain can be relieved with opiates. Effective opiate doses for pain control must 
increase and increase (Nusrat et al., 2012, Raffa and Pergolizzi, 2014). Eventually the patient 
becomes resistant to opiates. The alcohol and high fat chronic pancreatitis mouse model will be a 
tool for the research of chronic pancreatitis and possible medications that could for use by people 
with CP. 
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5 SIGNIFICANCE OF RESEARCH 
The AHF diet is generally similar, though not a perfect match, of the overconsumption of 
alcohol as well as a high calorie diet seen etiologically in humans that develop alcoholic 
pancreatitis (Irving et al., 2009, Yadav and Lowenfels, 2013). While humans eat a wide variety 
of diets, the laboratory environment required a homogenous diet of either Teklad 8626 (Teklad 
#8626, Harlan, Indianapolis, IN), or TestDiet LD101A (TestDiet LD101A, Richmond, IN). 
Teklad 8626 is a standard chow fed to mice in scientific environments. The first eight ingredients 
of Teklad 8626 pellets are ground wheat, fish meal, dried skimmed milk, porcine fat, soybean 
oil, casein, wheat middlings, and brewers dried yeast. The first eight ingredients of the liquid 
AHF TestDiet 101A mix are vitamin-free casein, olive oil, maltodextrin, dried corn syrup, soy 
fiber, corn oil, suspension colloid, and safflower oil. Please see Appendix B and C for the 
nutritional analysis. Laboratory conditions for mice are different than those faced by humans. 
However, consumption of the AHF diet does mimic two factors, overconsumption of alcohol 
seen in alcoholic chronic pancreatitis, as well as a high fat diet. 
 Diets high in fat and alcohol increase exposure to etiological risk factors for pancreatitis. 
Takano et al. (1992) showed that stress, which can both cause and be caused by anxiety (Steimer, 
2011), can aggravate CP progression. Production of this nontransgenic mouse model of AHF-
induced CP without the use of injected chemicals, provides a model more closely focused on the 
etiology of human pancreatitis In addition, the production of this model in mice allows for the 
future use of transgenic mice to further the study of alcoholic pancreatitis and associated 
conditions. The AHF CP mouse model also allows for study of the effects of anxiety on 
pancreatitis histology.  
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6 RESEARCH STUDY DESIGN 
6.1 Study Model 
The mice used in the study were floxed TGFβ1flox-ex6 on a mixed C57BL/6 background, 
from a strain maintained at The Jackson Laboratory. These mice were without the ability to 
express Cre recombinase. Without Cre recombinase floxed TGFβ1 cannot be removed using the 
cre-lox system. The mice were in a pre-knock-in/knock-out condition, so are otherwise normal. 
 This paragraph highlights the Lieber & DeCarli (1989) diet which is used with varying 
success by many researchers, and illustrates how the mice were fed alcohol on a certain 
schedule, as well as dietary high fat. Mice were fed a liquid diet including up to 6% alcohol. The 
first week the mice were given the liquid diet with 0% alcohol, then they were given 4%, then 
5%, and finally they were maintained at 6% for the remainder of the research. The diet is 
composed of 57% fat contributed by corn oil in the liquid diet as well as supplemental lard. This 
liquid diet is a modified Lieber & DeCarli (1989) diet used with great success in our lab to 
induce CP in rats (Yang et al., 2008, Zhang et al., 2014, McIlwrath and Westlund, 2015), 
confirmed using histology of the whole pancreas following sacrifice of the rats, as well as studies 
of nociceptive behavior. The success of the diet in rats, and the genetic similarity of mice to rats, 
allowed the expected result to be chronic pancreatitis. The presence of CP in this new mouse 
model was confirmed by analyzing pancreatic tissue for focal fibrosis, atrophy, and degradation 
of acini ducts. 
  The production of this mouse model allowed study of anxiety- and fear-like behaviors, as 
well as CP in older mice. Typical mice used for experimentation are 8 weeks old. This study 
began with mice that were 4.5 months, or 18 weeks old. The age range in mice, from 4.5 to 9 
months old, spans about 20 human years and relates to adult human maturity proceeding from 
the early twenties to about forty years (Jackson Laboratory, 2011). The study timeline continued 
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for 19 weeks. Studying the model in older mice is important as the incidence of acute 
pancreatitis, often a precursor to CP, increases with age (Nusrat et al., 2012, Yadav and 
Lowenfels, 2013).  
6.2 Specific Aims and Study Design 
6.2.1 Specific Aim 1 Study Design: To support the hypothesis that mice fed a liquid 
alcohol and high fat (AHF) diet will develop hypersensitivity and sustain damage to the 
pancreas seen in chronic pancreatitis. The hypersensitivity and pancreatic damage seen in the 
AHF mouse model are consistent with that commonly seen in the AHF rat model of CP, namely 
the presence of pain-like behaviors, and markers for pancreatic damage such as fibrosis, fatty 
infiltration, and atrophy (see Table 4 below). 
 
Mice in the AHF group were fed the AHF diet for the duration of the study as described 
previously. The presence of pancreatitis was verified using pain-like behavior and tissue 
samples.  
A pharmacological study designed to alleviate CP-induced hypersensitivity by antagonizing the 
TRPV4 channel (HC067047) was conducted as shown in Figure 3 and in 6.3 Test Drugs. The 
experiment was designed to test whether antagonizing TRPV4 would decrease hypersensitivity 
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in AHF mice. If the mice developed CP, then antagonizing TRPV4 should decrease nociceptive-
related behaviors. If the mice had not developed CP then antagonizing TRPV4 should have no 
effect. Hypothesis: Mice with AHF-induced CP will show decreased nociceptive behaviors upon 
dosing with the TRPV4 antagonist.  
 
Figure 3. Experimental Design of TRPV4 Antagonist H067047 Testing. Experimental design 
to test that antagonizing TRPV4 decreased hypersensitivity in AHF mice nociceptive-related 
behaviors. 
 
Relevance to Aim 1. Hypersensitivity present in the AHF mice decreased with the addition of 
the TRPV4 antagonist. TRPV4 is present and active in the signaling of hypersensitivity in rats 
with pancreatitis (Ceppa et al., 2010). HC067047 decreased TRPV4 signaling in the AHF mouse 
model. This agrees with data from our lab indicating that HC067047 decreased signaling of 
TRPV4 in rats with alcohol and high fat induced chronic pancreatitis (Zhang et al., 2015).  
A mu-opioid receptor agonist, Loperamide HCL, was used next and was expected to 
increase endogenous opioid receptor signaling known to be present on the pancreatic nerves and 
thus decrease hypersensitive behavioral responses. Loperamide was applied as described below 
in Figure 4 and in section 6.3 Test Drugs. 
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Figure 4. Experimental Design of mu-Opioid Agonist Loperamide HCl Testing. 
Experimental design to test that activating mu-opioid receptors decreased hypersensitivity in 
AHF mice. 
 
6.2.2 Specific Aim 2 Study Design: To characterize anxiety- and fear-like behaviors in 
mice using non-reflexive tests. Hypothesis: Mice on the AHF diet will display higher 
anxiety- and fear-like behaviors than control mice in non-reflexive testing. While AHF-fed 
and control rats in other studies responded in a quantifiable manner to testing, such as the 
hotplate, mice are historically less reliable than rats using reflexive testing. For example, in the 
hotplate test mice showed very few differences in the typical threshold markers seen in rats such 
as licking the hind paw. Mouse testing methods returning reliable results were developed using 
non-reflexive methods to optimize behavioral testing in this AHF CP mouse model. The 
following assays were used to measure mouse anxiety- and fear-like behaviors: plus maze, open 
field, place preference and escape, counts of grooming, counts of rearing, and number of uncued 
freeze events. Non-reflexive testing allows for a more holistic view of the mouse study treatment 
groups, highlighting anxiety-like and fear-like behaviors present in the animal. Note that anxiety 
interacts with pain reported in the human clinical patient (Walsh et al., 2012, Bair et al., 2013), 
therefore, it is necessary to include anxiety testing in this mouse model of human disease for 
possible future research into the possibility of an anxiety/nociception interaction. While anxiety- 
and fear-like behaviors are not expected to be directly translatable to humans this is an 
understudied area of CP model research well suited for study in this model. 
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6.3 Test Drugs  
6.3.1 TRPV4 antagonist HC067047 
HC067047 is a potent and selective inhibitor of the transient receptor potential family 
cation channel 4 (TRPV4) (Everaerts et al., 2010). TRPV4 is found on nerves in the pancreas, 
and senses osmotic pressure as well as metabolites of alcohol (Ceppa et al., 2010). TRPV4 
increases in CP and serves a role in neurogenic inflammation and pain (Ceppa et al., 2010). 
Everaerts (2010) has shown that this antagonist inhibits the TRPV4 mediated response to heat 
and arachadonic acid. The antagonist is efficacious at 10 mg/kg when given intraperitoneally 
(i.p.). 
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HC067047 (2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl) 
phenyl] -1H-pyrrole-3-carboxamide) was obtained from TOCRIS (San Diego, CA. The efficacy 
of this drug for reduction of pain- and anxiety-like behaviors was tested in mice with CP. 
Injections were made intraperitoneally (i.p.) at 10 mg/kg, after which the mouse was returned to 
the home cage for at least 30 minutes. Testing began at 60 minutes after injection. This time 
frame was calculated as a time of high effectiveness using the HC067047 dose response curve 
generated by the authors of the Everaerts (2010) paper. Prolonged alcohol and high fat exposure 
has been shown to increase TRPV4 in pancreatic innate immune stellate cells in another study in 
our lab (Zhang et al., 2013). 
6.3.2 Mu-opioid Receptor Agonist Loperamide  
Loperamide HCL (4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-
diphenylbutanamide) is a peripherally restricted, mu-opioid receptor (MOR) agonist commonly 
used to treat diarrhea (Awouters et al., 1993). Loperamide was used to test the effects on 
behavioral measures of reducing peripheral nerve activation in mice with CP. Loperamide was 
suspended in a 20% solution of 2-hydroxypropyl-β-cyclodextrin (Sigma-Aldrich, Milwaukee, 
WI) in saline and diluted to the proper dose concentration. Loperamide injections were made i.p. 
at 0.4, 0.6, 0.8, or 1.2 mg/kg and testing began at 60 minutes after injection (Reichert et al., 2001, 
Everhart and Ruhl, 2009).  
 7 Statistical Analysis  
T-testing and repeated measures one and two-way ANOVA were used to analyze the 
results of testing. p values at less than 0.05 were significant. 
 
 
 
40 
 
8 ANXIETY AND ALCOHOL: RELEVANCE TO FUTURE STUDIES OF THE 
INTERACTION OF ANXIETY AND ALCOHOL 
8.1 Anxiety, Stress, and Disease 
8.1.1 Adaptation to Chronic Stress 
Anxiety is a manifestation of stress. Chronic stress decreases organ health due to 
interactions with stress adaptation in the body (Dallman et al., 2003). Mice with more 
stress/anxiety behavioral affect are likely to have decreased pancreatic health. The hypothesis 
tested is that AHF mice with visceral pain-like behaviors will display greater anxiety-like 
behaviors than the control group.  
8.1.2 Alcohol Abuse and Disease 
In humans, stressful events produce anxiety, which can increase harmful behaviors such 
as alcohol abuse (Kushner et al., 2005). An increase or maintenance of heavy drinking over a 
period of time has been shown to increase the chance of damaging the pancreas irreversibly, 
assisting in the development of CP (Schneider et al., 2012, Zechner et al., 2012). The risk of 
developing pancreatitis increases in an alcohol dose-dependent manner (Irving et al., 2009). 
8.1.3 Mouse Behaviors and Human Anxious Affect 
Affect has been shown to influence human reaction to pain stimulus, increasing severity 
of pain perceived (Bair et al., 2013). It has been demonstrated that counseling to relieve feelings 
of anxiety and manage stress decreases healthcare use (Madan et al., 2013) and therefore is likely 
to impact compliance in the case of patients with CP. Different mouse strains demonstrate 
different levels of behaviors equated with anxious/stressed affect in humans. Mice in the present 
research had nesting materials available, but additional materials such as paper tubes could be 
supplied. In future studies, because AHF mice demonstrate high anxiety-like behaviors, and 
disordered histology, the next step in continuing studies would be to determine if low anxiety 
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behavior mice show the same severity of pancreatitis histology. Gurfein et al. (2012) alleviated 
stress in mice by providing nesting material, a play tube, and a den-like home in the cage. 
Additions like these that are meant to decrease anxiety in mice could help to slow the 
progression of CP. Calming human stress/anxiety could slow the progression of CP in humans. 
8.1.4 Anxiety and Disease 
Nineteen million US adults experience anxiety disorders. The stress-depression-anxiety 
axis has been shown to contribute to the development of diseases such as CVD, HIV, and cancer 
(Krantz and McCeney, 2002, Leserman et al., 2002, Roy-Byrne et al., 2008). In light of the 
literature showing the acceleration of disease in the presence of psychological stressors, it is 
possible that an accelerated progression to CP through increased alcohol consumption, smoking, 
and higher fat content in the diet may occur. Future studies will determine the part anxiety plays 
in the observed histology of CP in the AHF-induced pancreatitis seen in this model. This 
dissertation research provides a new etiologically based model of CP, making study of the 
disease in mice more etiologically relevant to the disease seen in humans. 
9 INTRODUCTION TO CHAPTERS 
This dissertation is comprised of four chapters within the context of development of a 
new mouse model of diet-induced CP, and assessing anxiety- and fear-like behaviors present in 
control or treated animals in this new model. Chapter one consists of an introduction to the 
background and literature. Chronic physical and mental pain increase vulnerability to future 
threats, leading to increased mortality at a younger age. Chronic pain tends to increase as a 
person ages. People in chronic pain experience physical, social, and mental decreases in function 
(Figure 3) (Fine, 2011). Pain in this sense encompasses physical pain such as that of CP, as well 
as psychological pain manifestations such as anxiety. 
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 In chapter two, the specific aim was to produce a wild type mouse model of CP induced 
only by the consumption of an alcohol and high fat (AHF) diet. This diet has produced CP in 
rats. The production of a mouse model of CP is expected to pay dividends in decreased general 
costs of maintaining and feeding the mice, while allowing future studies on transgenic mice with 
AHF induced CP. Mice fed the AHF diet over a period of five months did demonstrate pain 
related behaviors, as well as histology indicative of CP. This supports the presence of face 
validity, which is defined by Campos as the presence of physical and behavioral characteristics 
of the disease (Campos et al., 2013). It is suggested that the impact of both alcohol and high fat 
in a non-surgical, nontransgenic mouse model of CP, better recapitulates etiological factors 
known or suspected of leading to the development of CP in human patients in clinic, and 
provides construct validity. Construct validity is shown by following the known etiology of the 
disease in models of the disease. The production of this novel “diet alone” induced CP mouse 
model answers the call of experts in the field of pancreatitis for a model with alcohol as an 
induction factor. Note that alcohol alone is unsuccessful in CP model induction (Reed, 2014). 
 Chapter three is an investigation into the presence of anxiety- and fear-like behaviors in 
AHF induced CP mice. Traditional methods of testing can return unreliable results in the mouse, 
in addition, non-reflexive methods require less training to learn and score, releasing highly 
skilled laboratory personnel to complete more complex testing. Mice fed the AHF diet showed 
significant behavioral readouts in non-reflexive testing paradigms in comparison with control 
mice. It is proposed that non-reflexive testing is a suitable method of behavioral testing in a 
mouse visceral pain model. Exploration of the AHF CP mouse model is important to determine 
relevance to the human pain-cycle of anxiety, depression, and pain. Modification of possible 
anxiety-inducing factors in humans at-risk for CP may produce a decrease in progression of 
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recurrent acute pancreatitis to CP; in the context of the mouse model, further testing would 
include enrichment of the home cage with nesting material and a dark hiding place to determine 
the effect on disease presence.  
Chapter four provides a summary, conclusions, and future work. Physiologic reserve 
tends to decrease as the body ages. Chronic physical and mental pain are symptoms of 
vulnerability and decreased homeodynamic space, leading to increased mortality at a younger 
age. Maintenance of high physiologic reserve is diminished in populations such as alcoholic 
chronic pancreatitis patients due to overconsumption of alcohol, and consumption of high fat 
foods. Alcohol and high fat foods can be comforting and assist in an individual’s control of stress 
in their life (Gilman et al., 2008, Tomiyama et al., 2011) 
 One way to help add more years to life and more life to years is to understand why 
disease affects people in populations heterogeneously, and study how to relieve the symptoms of 
painful diseases such as CP. The study of CP in a non-surgical mouse model is essential to 
understand the disease. The AHF diet induces the morbidity of CP in mice likely in an 
etiologically similar manner to that in humans. The research data presented here, as well as 
literature reviews on the subject, highlight the damage caused to the pancreas with continued 
overconsumption of alcohol in the presence of a high fat diet. 
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CHAPTER TWO 
A Mouse Model of Chronic Pancreatitis Induced by an Alcohol and High Fat Diet 
 
ABSTRACT 
Background/Aims: While study of acute pancreatitis in chemically-induced rodent models has 
provided useful data, models of alcoholic chronic pancreatitis induced only by diet have not been 
available in mice. The aim of the present study was to characterize a mouse model of CP for 
laboratory study induced with an alcohol and high fat (AHF) diet.  
Methods: Mice were fed normal chow ad libitum or a liquid high fat diet containing 6% alcohol 
as well as a high fat supplement (57% total dietary fat) over a period of five months. Hind paws 
of the mice were tested for mechanical hypersensitivity with von Frey filaments and the 
mechanical plate. A modified hotplate testing procedure determined higher order responses to 
visceral hypersensitivity. Mice underwent mechanical and thermal testing both with and without 
pharmacological treatment. Pharmacological agents tested were a peripherally restricted µ-opioid 
receptor agonist, Loperamide or a TRPV4 antagonist, HC067047. 
Results: Mice on the AHF diet exhibited mechanical and heat hypersensitivity as well as 
histopathology indicative of chronic pancreatitis. Loperamide attenuated both mechanical and 
heat hypersensitivity, while heat hypersensitivity decreased after TRPV4 antagonism.  
Conclusion: Mice fed an alcohol and high fat diet develop histopathology consistent with 
chronic pancreatitis, as well as opioid sensitive mechanical and heat hypersensitivity. 
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1. INTRODUCTION 
In 2004, pancreatitis cost the US $373.3 million in direct and indirect costs (Everhart and 
Ruhl, 2009). Eight in 100,000 people are diagnosed with CP in the US yearly (Yadav and 
Lowenfels, 2013) and up to 50% of these can live 20 years after diagnosis with CP (Braganza et 
al., 2011). Fifty out of 100,000 people are living with CP (Yadav et al., 2011b, Hirota et al., 
2012). Many of these patients endure severe intractable pain.  
The development of CP in humans results from multiple possible contributing risk factors, 
one of which, described by Forsmark (2013) is the sensitizing effect of alcohol on the pancreatic 
cells. Overproduction of extracellular matrix by alcohol-activated pancreatic stellate cells 
eventually promotes the fibrosis that interferes with pancreatic functions (Masamune et al., 
2009). This overproduction occurs as pancreatic stellate cells attempt to repair damaged 
pancreatic cells (Siech et al., 2009). It has been suggested that high levels of alcohol also 
decrease the solubility of proteins in the ductal space, leading to plugging of the ducts and the 
subsequent autodigestion of the pancreas (Braganza et al., 2011).  
The National Commission on Digestive Diseases (NCDD) under the umbrella of the National 
Institute of Diabetes and Digestion and Kidney Diseases (NIDDK), value the production of 
better animal models to further the study of alcoholic pancreatitis (Witt et al., 2007). Mouse 
models in which CP is induced only with a combination of ad libitum high fat liquid food with 
added alcohol and lard supplementation do not currently exist. Current rodent models of 
pancreatitis induced by chemical irritants such as cerulein or dibutyltin dichloride (DBTC) have 
proven fruitful for studies of acute pancreatitis (Perides et al., 2005). However, these models do 
not provide the range of symptoms for CP based on risk factors seen in the clinic.  
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The alcohol and high fat (AHF) diet proposed for  use in this model is a modified Lieber-
DeCarli (Lieber and DeCarli, 1989) diet containing 6% ethanol, added corn oil (20% fat) and 
supplemental lard. This liquid diet has been used with great success in rats to induce CP, 
confirmed using histopathology of the pancreas and pain-related behavioral studies (Yang et al., 
2008, Zhang et al., 2014, McIlwrath and Westlund, 2015, Zhang et al., 2015). The purpose of the 
present study is to produce an AHF diet-induced CP mouse model, characterize pancreatic 
pathology, and also the pain-related behaviors which develop in mice fed the alcohol and high fat 
diet. Histopathological confirmation of pancreatitis includes evidence of significant pancreatic 
fibrosis, as well as diffuse nuclear material, and poor cellular architecture. 
2. METHODS 
The studies were performed in accordance with the Guide for the Care and Use of Laboratory 
Animals published by the National Institutes of Health. All procedures were approved by the 
University of Kentucky Institutional Animal Care and Use Committee. 
2.1 Induction of Pancreatitis 
Five month old male mice on a C57BL/6 background weighing less than 40g (The 
Jackson Laboratory) were used for this study. Animals were housed at 21-24°C, on a reverse 
light:dark 14:10 hour schedule. Control mice were fed rodent chow (Mouse Breeder Diet 8626, 
10.4% fat) from Teklad (Madison, WI). AHF pancreatitis mice were fed liquid diet from Test 
Diet (LD101A, Richmond, IN) and supplementary fat (lard and corn oil). The total fat content 
was ~57%. Alcohol was gradually added to the diet over a period of weeks from zero, to 4%, 
5%, and then 6%. AHF fed mice were maintained at 6% alcohol for the remainder of the study. 
Body weight was monitored weekly. 
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2.2 Assessment of Pain Related Behaviors  
2.2.1 Paw Withdrawal Threshold (PWT) Testing   
  Mice were loaded into Plexiglas rectangles (7x4x4 cm) on a raised wire-bottomed table 
and allowed to acclimate for 30 minutes. Von Frey filaments were applied in a methodical 
manner to the plantar surface of the mouse hind paws as described in Chaplan et al. (1994) to 
assay mechanical thresholds. The von Frey monofilaments ((4.74) 6.0g; (4.31) 2.0g; (4.08) 1.0g; 
(3.61) 0.4g; (3.22) 0.16g; (2.83)0.07g; (2.36) 0.02g; (1.65) 0.008g)) were applied perpendicular 
to the plantar surface until just bent and held for 5 seconds. A positive response was scored when 
the paw withdrawal response was observed (animal picked up its foot, flicked it) away from the 
monofilament either during the time the filament was pressed against the plantar surface or just 
after it was removed. The up-down method suggests that when a positive response is scored, the 
next lower filament is used, while if there is no response (negative response), the next higher 
filament is used. Testing continued until an additional four filaments returned a positive or 
negative response. The up-down algorithm was then used to calculate the 50% paw withdrawal 
mechanical threshold (in gram force) (Chaplan et al., 1994). The decreased paw withdrawal 
threshold is an indication of mechanical allodynia.   
2.2.2 Smooth or Rough Mechanical Plate  
Rearing exploratory activity, including frequency and duration, with or without a rough 
textured floor insert (the textured side of a polystyrene ceiling light panel diffuser (89091), 
Lowes.com), was monitored in real time and captured using custom software during 5 min 
tests.  The test apparatus consisted of a clear Plexiglas box (11cm X 8cm X 8cm) placed upon 
either a smooth or roughly textured surface.  
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2.2.3 Modified 44°C Hotplate Assay 
The procedure is as in Kline and Wiley (2008), and will be described here. In modified 
44°C hotplate testing, mice were first placed on a 38°C hotplate for ten minutes in order to 
slowly pre-warm the animal’s foot. Thereafter the mice were moved to a 44°C hotplate  for a ten-
minute testing period (Kline and Wiley, 2008). In this study, jumping events, rearing events, and 
latency to first jump were the dependent variables and were recorded using custom software.  
2.3 Test Drugs 
2.3.1 Mu-opioid Receptor Agonist  
Loperamide HCl (SIGMA-Aldrich, Milwaukee, WI) is a peripherally restricted, mu-
opioid receptor (MOR) agonist commonly used to treat diarrhea (Awouters et al., 1993). 
Loperamide HCl was suspended in a 20% solution of 2-hydroxypropyl-β-cyclodextrin (Sigma-
Aldrich, Milwaukee, WI) in saline and diluted to the proper dose concentration. Loperamide HCl 
injections were made intraperitoneally (i.p.) at 0.4, 0.6, 0.8, or 1.2 mg/kg and testing began at 60 
minutes after injection (Reichert et al., 2001, Everhart and Ruhl, 2009).  
2.3.2 TRPV4 antagonist 
The TRPV4 antagonist, HC067047, was obtained from TOCRIS (San Diego, CA). 
Everaerts et al. (2010) have shown that this antagonist is a potent and selective inhibitor of the 
TRPV4 channel mediated response to heat, arachadonic acid, and 4α-phorbol 12, 13-dihexanoate 
(4α-PDH). Injections were made intraperitoneally (i.p.) at 10 mg/kg, after which the mouse was 
returned to the home cage for at least 30 minutes. Testing began at 60 minutes after injection. 
This time frame was determined as the peak effectiveness using the TRPV4 antagonist dose 
response curve generated by the authors of the Everaerts paper (Everaerts et al., 2010). 
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2.4 Histology 
Histology was carried out using a modified method described as in our previous paper 
(Zhang et al., 2014). Mice were perfused transcardially with a 4% paraformaldehyde (PFA) 
solution after which the entire pancreas was excised and post-fixed in a 4% PFA solution 
overnight, then changed to 70% alcohol. After dehydration through graded ethanol (95, 100%), 
the pancreases were embedded in paraffin, and sectioned into 10 µm thickness using a 
Heidelberg Microm 350 microtome.  
2.4.1 Sirius Red Staining for Collagen  
Pancreatic sections were deparaffinized and rehydrated. The tissues were stained with 
Sirius Red (0.1%, EMS Hatfield, PA) and Fast Green was used as a counterstain. Stained tissue 
sections were examined under light microscopy for changes indicative of pancreatitis, with 
particular interest in fibrosis. A Nikon Eclipse E1000 microscope was used with a 20X objective 
to capture random images of five sections from each animal. Computer-aided fibrosis calculation 
requires the placement of a digital mask over the image, followed by computation of the amount 
of staining seen. Fibrosis is composed of collagenous material and is stained by Sirius Red. 
Fibrosis amount was calculated by computer-assisted densitometry using an overlay to determine 
the density of Sirius Red staining of collagenous proteins present in the tissue.  
2.4.2 Hematoxylin and Eosin (H&E) Staining 
Slides were de-paraffinized with Citrosolv (Fisher, Pittsburgh, PA), hydrated by down 
stepping ethanol (100%, 95%, 70%, 50%), rinsed in tap water, and immersed in 0.1% 
hematoxylin (Fisher, Pittsburgh, PA) for 1 minute. Then slides were washed in tap water for 1 
minute, dehydrated by stepping up ethanol percentage (50%, 70%, 95%), immersed in 0.1% 
eosin (in 95% ethanol, Fisher, Pittsburgh, PA) for 1 minute, and then cleaned and dehydrated in 
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95% ethanol. Finally, sections were dehydrated in 100% ethanol, then Citrosolv, and cover-
slipped with Permount (Fisher, Pittsburgh, PA). 
Stained slides were imaged using a Nikon Eclipse E1000 microscope equipped with the 
ACT-1 program. Five randomly chosen sections from each treatment group were analyzed for 
tissue morphological changes and fibrosis. All images of the sections used in the analysis were 
captured with the same background level set based on the control group unstained white area in 
the section. Illumination levels and microscope settings were maintained through collection of all 
data samples.  
2.5 Statistical Analysis 
The data were expressed as means±S.E. Comparisons among groups at different time points 
or different doses were performed with a two-way analysis of variance (ANOVA) followed by 
Tukey’s multiple comparisons post tests using SigmaPlot version 12.0 (Systat Software, San Jose 
California, USA). Two-tailed t-tests were also used where appropriate. A p≤0.05 was considered 
significant.       
3. RESULTS 
3.1 AHF Fed Mice Showed Chronic Pancreatitis Morphology with Increased Fibrosis 
The pancreatic histology of mice fed the alcohol and high fat diet showed morphological 
disruption common to CP: atrophy, diffuse nuclear material and poor cellular architecture 
(Figure 5B) versus the histological uniformity in control mice (Figure 5A and 5C). Fatty 
infiltration lipid vacuoles were easily seen in the pancreatic tissue of AHF pancreatitis mice 
along with some tumor-like structures. Increased fibrosis was evident in AHF animals (Figure 6). 
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Pancreatic histology shows significantly increased fibrosis in sections from AHF 
pancreatitis mice compared to that of controls. Fibrosis is composed of collagenous material and 
is stained by Sirius Red. Figure 5 shows representative pancreatic sections from both control (A 
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Figure 5. Chronic pancreatitis histopathology is evident in tissue sections from AHF 
pancreatitis mice. Pancreatic tissue sections from control mice show typical structural 
morphology (A) and (C). (B) Increased intralobular space (white arrowheads), 
degradation of acinar cells (white arrow), and (D) fibrosis (black arrowheads) in mice 
with AHF chronic pancreatitis.  
Figure 6. Increased percent 
fibrosis in AHF pancreatic tissue. 
Histogram showing significantly 
increased percent fibrosis of total 
tissues in AHF pancreatitis mice 
versus that of control mice (p<0.02, 
two-tailed t-test). Error bars are 
±SEM.  
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& C) and AHF pancreatitis mice (B & D) stained with Sirius Red and Fast Green. Note the 
atrophy and increased fibrosis in Figure 5C versus 5D. The percent fibrosis of the total tissue 
was significantly higher in the AHF pancreatitis mice (21±2.7 % of total tissue). In contrast, the 
percent fibrosis of the total tissue in the normal chow controls was 5.5±1.2 % (Figure 6). There is 
a significant difference between AHF pancreatitis animals and normal chow controls (p<0.02, 
two-tailed t-test).  
3.2 Mice with AHF Pancreatitis Developed Secondary Mechanical Allodynia  
Secondary mechanical hypersensitivity was assessed by testing both the paw withdrawal 
threshold (PWT, Figure 7A) and the rough or smooth mechanical plate (Figures 8 and 9). The 
50% hind paw withdrawal thresholds to intermittent mechanical stimulation in the mice were 
measured over a four week period to establish a baseline prior to drug testing. The 50% paw 
withdrawal thresholds of mice with CP were significantly decreased (0.49±0.16g) compared to 
those of normal chow controls (1.33±0.23g; p<0.05 by two-way ANOVA, Tukey post hoc test) 
(Figure 7A).  
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3.2.1 Loperamide Attenuated the PWT Secondary Mechanical Hypersensitivity 
To test if the hypersensitivity induced by the AHF diet is pain related, the peripherally 
restricted mu-opioid agonist, Loperamide was given.  AHF pancreatitis mice injected i.p. with a 
0.6 mg/kg dose of Loperamide HCL showed a significant elevation in hind paw withdrawal 
thresholds to non-noxious mechanical stimulation compared to that of saline treated AHF 
pancreatitis animals at 1hr (0.925±0.325g vs. 0.241±0.177g) and 2hr (1.102±0.346g vs. 
0.146±0.099g) post injection (p<0.05 by two-way ANOVA, n=4 AHF+vehicle, n=6 AHF+LOP). 
The effect lasted for three hours and peaked at the two hour time point (Figure 7B).  
3.2.2 Loperamide Decreases Mechanical Hypersensitivity on the Mechanical Plate 
The smooth or rough mechanical plate was used to assess higher brain order responses to 
the mechanical stimulus. The test device consisted of an acrylic sheet with either a rough 
diamond pattern providing an uneven surface or a smooth surface that mice were placed upon. 
Figure 7. PWT is decreased in the AHF group. (A) 50% hind paw withdrawal 
thresholds to intermittent mechanical stimulation in the chronic pancreatitis AHF mouse 
model are significantly decreased versus normal chow controls (p<0.05 by two-way 
ANOVA, Tukey post hoc test, n=6 per group). Loperamide attenuated AHF-induced 
mechanical hypersensitivity (B). Loperamide treated AHF pancreatitis mice showed a 
significant elevation in hind paw withdrawal thresholds to intermittent mechanical 
stimulation compared to saline treated AHF pancreatitis animals at 1hr and 2hr after 0.6 
mg/kg dose of Loperamide i.p. (p<0.05 by two-way ANOVA, n=4 Control, n=6 AHF). 
Error bars are ±SE. 
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The number of rearing events and rearing duration were recorded using custom software. Mice 
fed the AHF diet showed a 67% increase in exploratory behavior with intent to escape (rearing 
events, 39±3.5) on the rough surface sheet (Figure 8A) which gave continuous mechanical 
stimulation of the plantar hind paws compared to controls (rearing events, 26±3.9; p=0.044 by 
two-tailed t-test; n=7 Control, n=6 AHF). AHF pancreatitis mice also displayed an increased 
rearing duration (64±14.5s; n=6) on the rough surface plate (Figure 8B) compared to that of 
normal chow controls (28±6s; p=0.035 by two tailed t-test; n=7). In contrast, neither the number 
of rearing events nor the rearing duration showed any significant difference between the two 
groups on the smooth surface plate.  
 
 
 
 
Loperamide HCl i.p. injection at 0.6 mg/kg decreased treated AHF group rearing events 
and duration significantly relative to the uninjected AHF control group (Figure 9). This indicates, 
as seen in the intermittent mechanical stimulation of the von Frey test, that escape behavior of 
Figure 8. AHF fed mice show elevated baseline escape behavior to rough surface 
flooring, a mechanical stimulation. Mice fed the AHF diet show a significant increase in 
number of rearing events (A), and significant prolonged rearing duration (B) to continuous 
mechanical stimulation of the plantar hind paws compared to that of normal chow controls 
(p=0.044 and p=0.035 respectively by two-tailed t-test; n=7 Control, n=6 AHF). Error bars 
are ±SEM. On the non-noxious smooth surface neither the number of rearing events (A) nor 
rearing duration (B) showed any significant difference between the two groups.  
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AHF mice to continuous mechanical stimulation experienced on the rough mechanical plate is 
pain-related. 
 
Figure 9. Loperamide HCL treatment decreases rearing and rearing duration in AHF Mice. 
AHF mice treated with Loperamide display significant reversal of both increased rearing events 
(A), and rearing duration (B). (p=0.045 and p=0.051 respectively by two-tailed t-test; AHF 
Control n=6, AHF Loperamide n=6). 
 
3.3 AHF Pancreatitis Mice Developed Nocifensive Behaviors on Hot Plate Testing 
The modified 44°C hotplate was used to determine heat sensitivity of mice in the study. 
The number of rearing events at baseline testing of 38°C showed little difference between AHF 
pancreatitis and normal chow control mice (23±6.8 vs. 20±6.7 rearing events) (Figure 10A). 
AHF pancreatitis mice, however, showed a significantly increased (55%) number of rearing 
events (60±8 events) (indicating escape behaviors) on the modified 44°C hotplate than did 
normal chow control mice (33±2; p=0.011; by two tailed t-test) (Figure 10B).   
3.4 Loperamide Attenuated the Nocifensive Response to the 44°C Hotplate Stimuli in a 
Dose Dependent Manner 
Baseline rearing events at 38°C showed little difference between AHF pancreatitis and 
normal chow control mice (Figure 10A). AHF pancreatitis mice showed a significantly greater 
number of rearing events (60±7.5) on the baseline modified 44°C hotplate than did normal chow 
Control mice (33±1.5) (Figure 10B). Systemic Loperamide (i.p.) produced a dose-dependent 
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decrease in AHF pancreatitis mouse rearing events (0.4 mg/kg; 37±5, 0.8mg/kg; 31±4 events, 
1.2mg/kg; 28±5). Vehicle treated AHF pancreatitis mice showed a significantly higher number of 
rearing events at 44°C than did the Loperamide 1.2mg/kg dose treatment group (38±4), (p<0.05 
by two-way repeated measures ANOVA (Figure 10C).  
3.5 HC067047 Significantly Shifted the Event-time Curve Right-ward  
The TRPV4 antagonist, HC067047 (10mg/kg; i.p.), significantly decreased the number of 
jump events (52%) in AHF pancreatitis mice in modified 44°C hotplate testing 13±5.3, 
(AHF+HC, n=6) vs. 25±10.2 (AHF+vehicle, n=7); (p=0.028 by two-tailed t-test).  The latency to 
first jump event was prolonged in HC067047 treated AHF pancreatitis mice by 51% (321±111s 
(AHF+HC) vs. 136±58s (AHF+vehicle)). The number of jump events decreased while the 
latency to first jump was prolonged in AHF pancreatitis animals treated with HC067047. The 
event-time curve showed a significant right-ward shift (Figure 10D).  
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4. DISCUSSION 
The aim was to produce an alcohol and high fat induced mouse model of CP for 
laboratory study. Models of CP have been called for by those prominent in the field of 
pancreatitis research (Witt et al., 2007). The diet induced model discussed here was intended to 
be effective in nontransgenic mice to produce a model of CP that more closely resembles the 
development of the disease in humans. The epidemiology of pancreatitis shows two times the 
Figure 10. AHF pancreatitis mice exhibit an increase in rearing events in response to 
heat stimulation at 44°C. (A) The number of baseline rearing events at 38°C showed little 
difference between AHF pancreatitis and normal chow control mice. (B) AHF pancreatitis 
mice showed significantly more rearing events on the continuously stimulating modified 44°C 
hotplate at baseline than did normal chow control mice (p=0.011; by two tailed t-test). (C) 
AHF pancreatitis mice with systemic Loperamide treatment showed decreases in the number 
of rearing events in a dose-dependent manner (at 1.2mg/kg dose, vs. AHF+Vehicle, p<0.05 by 
two-way repeated measures ANOVA). (D) The TRPV4 antagonist, HC067047 significantly 
prolonged the latency to first jump in AHF pancreatitis mice versus vehicle treated AHF 
pancreatitis mice on the 44°C modified hotplate (p<0.05 by two-way repeated measures 
ANOVA, Tukey’s Test; n=7 AHF+Vehicle; n=6 AHF+HC). The event-time curve showed a  
significant right-ward shift. Error bars are ±SE.  
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chance of diagnosis of the disease in overweight and obese people; it also shows that of those 
with CP, 70% abuse alcohol (Martinez et al., 2004, Siech et al., 2009). This model, incorporating 
alcohol and high fat, provides two long term “hits” to the system of the mouse and produces a 
deleterious burden in body homeostasis leading to tissue damage (CP) with pain related 
complications. 
In the characterization of a new model, showing that the model has the disease targeted 
effects is an important first step. The model was reliably produced in all mice fed the AHF diet. 
Histology conducted on the pancreas of AHF pancreatitis mice showed morphology common to 
CP: fibrosis, diffuse nuclear material, poor cellular architecture, and fat vacuole formation. 
Increased fibrosis is a common feature in CP due to the activity of pancreatic stellate cells (PSC). 
In the presence of alcohol and fatty acids, these normally quiescent PSCs become activated 
(Zhang et al., 2013). Activated PSCs synthesize and secrete endogenous cytokines which 
influence PSC function via autocrine pathways. This leads to excessive extracellular matrix 
(ECM) production, eventually causing wide spread pancreatic fibrosis, and the persistent damage 
seen in CP. Percent pancreatic fibrosis in the AHF pancreatitis mice was significantly greater 
than that of normal chow controls. The increased fibrosis in AHF pancreatitis mice likely 
indicates that PSCs were activated and overproducing ECM within the pancreas of AHF 
pancreatitis mice.  
Correspondent to the morphological changes within the pancreas, AHF pancreatitis mice 
showed hypersensitive behaviors in both mechanical and thermal testing. AHF pancreatitis mice 
displayed secondary mechanical allodynia on their hind paws as demonstrated by the decreased 
paw withdrawal threshold. Correspondingly, AHF pancreatitis mice showed significantly 
increased numbers of rearing events on the rough surface at baseline. AHF pancreatitis mice also 
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exhibited significantly increased numbers of rearing events on the 44°C modified hotplate. 
Vierck et al., (2002) determined that temperatures from 43°C to 45°C can provide C fiber 
activation. Chronic pain in the clinic has been associated with prolonged activation of the C-
nociceptors (Yeomans et al., 1996). 
Laboratory animal drug testing has traditionally been concerned with relieving acute pain 
stimuli such as that seen on the hotplate test. Acute testing tends to focus on pain carried by the 
Aδ afferents, also known as “first pain”. Chronic pain is a significant problem for patients in the 
clinic and one that is most important to address. Slow increases of nociceptive stimuli such as 
heat tend to replicate the type of pain seen in humans in the clinic as it activates C-fiber 
nociceptors preferentially. 
The reality of first and second pain show that all pain is not alike. First pain is immediate 
upon exposure to a painful stimulus. Descriptors of this pain in humans include “sharp” or 
“stabbing”. First pain is carried by myelinated Aδ fibers. The myelination allows quick 
movement of the afferent pain signal to the brain. Aδ fibers conduct signals at a speed of (5-30 
m/s) to the brain. Second pain is delayed pain felt after first pain subsides. Descriptors of this 
pain in humans include “dull” or “throbbing”. Second pain is carried by small unmyelinated C-
fibers. The lack of myelination means slow movement of the afferent pain signal to the brain. 
Indeed, the C-fiber carries signals at a rate of (0.5-2 m/s) to the brain, compared to the A delta 
fibers at (5-30 m/s).  
Drugs that have been tested against first “pain” in laboratory animal trials don’t always 
prove effective in treating second “pain”. This is because first pain activates the A delta 
nociceptors while second pain activates the C-fibers. Second pain in laboratory animals is 
comparable to chronic clinical pain in humans. Locating analgesics specific to the nociceptive 
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fiber responsible for “pain” signaling is expected to provide relief to humans and a decrease in 
pain-like behaviors in laboratory animals. The nociceptors actively targeted in the modified 
hotplate procedure are specific to C-fibers. Vierck et al., (2002) determined that temperatures 
from 43°C to 45°C can provide C fiber activation. 
C-fibers were preferentially activated during testing of the analgesic properties of HC 
067047, or Loperamide HCl. HC067047 showed a trend of effectiveness against heat induced 
nociceptive stimuli. HC067047 could therefore be active against pain in humans as it treats C-
fibers in mice. 
The 44°C hot plate stimulus is considered a noxious continuous stimulation. The AHF 
pancreatitis mice had an increased nocifensive response to the 44°C modified hotplate stimulus, 
i.e. jumping. The increase in jumping responses are indicative of secondary heat hyperalgesia. 
This pancreatitis associated secondary hypersensitivity can be effectively attenuated by systemic 
application of either Loperamide HCL, a peripherally restricted mu-opioid agonist; or HC06704, 
a TRPV4 channel antagonist.  
Loperamide was used to avoid central effects as we only wanted to affect the peripheral 
nerve innervation of the pancreas (Khawaja et al., 1990, Khalefa et al., 2012). The use of pain 
relief drugs in humans can cause impairments as the drugs cross the blood-brain barrier 
(Ringkamp and Raja, 2012). The peripherally restricted action of Loperamide is meant to avoid 
effects of central impairment in mice in the study, and later in humans. Therefore, Loperamide 
was chosen to agonize the mu-opioid receptors in the peripherally-located damaged pancreatic 
tissue. 
Loperamide is best known for its antidiarrheal properties, but it has found limited use as a 
peripherally restricted agonist of the mu-opioid receptor (MOR) system (Kumar, 2013). 
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Loperamide is a non-addicting, mu-opioid agonist expected to bind mu-opioid receptors in the 
pancreas, inhibit neurotransmitter release, and decrease calcium influx to the cell. Mu-opioid 
receptors are increased in damaged pancreatic tissue (Lu et al., 2007). Loperamide likely 
provided analgesic effects by decreasing nociceptive signaling through mu-opioid receptors on 
pancreatic nerves. Blunting the nociceptive stimulation from the pancreas by MOR activation 
was expected to decrease mouse mechanical and thermal hypersensitivity. 
In this study, antagonism of TRPV4 channels in AHF pancreatitis animals attenuates 
nocifensive behaviors. The first jump latency is significantly prolonged, while the number of 
jump events on the hotplate decreases in HC067047 treated AHF pancreatitis mice. This is 
indicative of decreasing escape behavior following TRPV4 antagonist treatment. Everaerts 
(2010) determined that HC067047 produced potent and selective inhibition of TRPV4 channel 
activity in a bladder inflammation model. Zhang et.al (2013) have shown that the expression of 
the TRPV4 channel is increased in activated pancreatic stellate cells in the AHF CP rat model. 
Miranda et al. (2014) have shown the presence of TRPV4 in the pancreatic dorsal root ganglion 
as well as pancreatic nerve fibers. In this study, the enriched metabolites of alcohol and fatty 
acids likely activate TRPV4 receptors in the nerve endings, making them spontaneously active, 
or more readily activated, causing an amplification of nociceptive signaling. Following 
antagonism of TRPV4 channels, the prolonged first jump latency and decrease in number of 
jump events is denoted by an event-time curve right-ward shift similar to that seen following 
treatment with morphine (Dirig and Yaksh, 1995).  
5. CONCLUSION 
The data presented here are evidence supporting the successful production of an AHF 
diet alone induced mouse model of CP. The successful reduction of pain related behaviors by 
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both Loperamide and HC067047 suggest that the CP model showed responsiveness to activation 
of opioid receptors, as well as increased activation of TRPV4 channels in the pancreas and 
peripheral nervous system. Loperamide, a peripherally restricted mu-opioid receptor agonist, 
attenuated both mechanical and heat hypersensitivity in the mouse CP model. The TRPV4 
antagonist, HC067047 reduced heat hypersensitivity. This implies that either TRPV4 
antagonism, or agonizing the peripheral opioid system (Loperamide) can be used to inhibit 
visceral pain signaling associated with CP. 
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CHAPTER THREE 
Anxiety- and Fear-like Behaviors in a Mouse Alcohol and High Fat Chronic Pancreatitis Model 
 
ABSTRACT 
Background/Aims: The previous study characterized pain related responses in an Alcohol and 
High Fat (AHF) diet-induced mouse model of CP. The aim of this study is to characterize 
anxiety-like behaviors in this chronic pain mouse model.   
Methods: Mice were fed normal chow ad libitum or a liquid diet containing 6% alcohol and a 
high fat supplement over a period of five months. Anxiety-like behavior, escape behavior, and 
locomotion were measured using the following: Place Preference testing including the light/dark 
box and  44°C/22°C escape test; plus maze, open field, the smooth or rough mechanical plate, 
and a modified 44°C hotplate procedure. Pharmacological agents tested in the modified hotplate 
test were a peripherally restricted mu-opioid (Loperamide HCl) and a TRPV4 antagonist. 
Results: Overall AHF mice have increased anxiety-like behaviors displaying both more 
exploration/escape responses and increased locomotion. The AHF mice also show increased 
fear-like freezing behavior on the modified 44°C hotplate. In the open field test AHF mice 
showed similar mobility and decreased escape behaviors relative to controls. 
Conclusion: A test battery including light/dark place preference, and 44°C/22°C escape testing, 
plus maze, open field, and the modified hotplate can be used to better understand anxiety-like 
behavior in a mouse model of CP. AHF mice display increased anxiety-like behaviors, providing 
an experimentally analogous model of the anxiety shown by patients diagnosed with CP pain.  
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1. INTRODUCTION  
The correlation of CP hypersensitivity with anxiety and stress-induced analgesia (SIA) has 
been understudied. Nineteen million adults (18%) in North America experience anxiety disorders 
(Cryan and Holmes, 2005) while 35% of patients in chronic pain have anxiety (McWilliams et 
al., 2003). Up to 75% of people diagnosed with CP experience terrible pain as the disease 
progresses (Di Sebastiano et al., 2000, Madan et al., 2013). Therefore, the percent anxiety in the 
population of patients with CP is likely to be higher than that seen in the general public. While 
data concerning the percent of patients with CP pain comorbid with anxiety are not available, 
decreased QoL is well established in pancreatitis patients (Pezzilli et al., 2005, Mullady et al., 
2011, Walsh et al., 2012, Amann et al., 2013). Patients with anxiety experience lower QoL 
(Brenes, 2007). People with CP experience anxiety (Walsh et al., 2012). Using a battery of tests 
to determine the presence of anxiety-like behaviors in a mouse model of CP allows exploration 
of CP mouse model characteristics that mirror those of patients diagnosed with CP. Increased 
similarity between the patient and mouse model increases translatability to clinical patients with 
CP.  
Anxiety, like pain, is useful as a transient state but when anxiety is prolonged it is termed a 
disorder. Anxiety of this kind is characterized by “a marked, persistent, & excessive or 
unreasonable fear” (DSM-4) that interferes with normal life (Roy-Byrne et al., 2008). Steimer 
(2002) suggested that anxiety is defined as “a psychological, physiological, and behavioral state 
induced in animals and humans by a threat to well-being or survival, either actual or potential.” 
Anxiety is often comorbid with pain and depression (Kroenke et al., 2013). Studies of life stress 
have shown that it accelerates the progression and severity of diseases such as cardiovascular 
disease (CVD) (Krantz and McCeney, 2002), HIV (Leserman et al., 2002), and depression 
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(Hammen, 2005). Both chronic stress and anxiety can lead to and be comorbid with decreased 
health (Roy-Byrne et al., 2008, Tomiyama et al., 2011). It is critical to determine the part anxiety 
and stress play in the observed pathology of CP because CP patients display increased anxiety 
(Walsh et al., 2012). 
Stress-induced analgesia (SIA) occurs when exposure to stressful stimuli causes suppression 
of pain. SIA occurs in humans as well as other species such as the mouse. SIA is activated upon 
intense stimulation of pain-related circuitry (Rhudy and Meagher, 2000), such as after receiving 
an injury in war (Beecher, 1946), or during a marathon (Janal et al., 1984). SIA has also been 
observed in animals. Anxiety-like behaviors in rodents are easier to detect after 6-8 weeks of 
chronic pain (Yalcin et al., 2011, Yalcin et al., 2014). SIA in the rodent can be induced in a 
number of ways including exposure to electrical foot shock, or hotplate (Amit and Galina, 1986, 
Butler and Finn, 2009). It is thought to be an evolutionary survival response allowing an injured 
animal to escape further injury by deadening a distracting immediate response to algesic stimuli 
such as bodily injury (Butler and Finn, 2009). SIA gives the animal time to leave the dangerous 
environment where it received injury. To test the induction and presence of SIA in the AHF CP 
mouse model, we will use both the 44°C hotplate, and the 44°C/22°C Escape Place Preference 
test.  
A variety of measures were used to test anxiety in the AHF CP mouse model including 
testing in the Open Field, Plus Maze, Smooth or Rough Mechanical Plate, 44°C Modified 
Hotplate, Place preference Light/Dark Box, as well as a 44°C/22°C Escape test. These tests are 
designed to assess anxiety-like behaviors, stress-induced analgesia, mechanical and thermal 
hypersensitivity, and spontaneous exploration behavior. We anticipated that AHF-diet induced 
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CP mice would display increased anxiety-like behavior and stress-induced analgesia relative to 
control mice. 
2. METHODS 
The studies were performed in accordance with the Guide for the Care and Use of 
Laboratory Animals published by the National Institutes of Health. All procedures were 
approved by the University of Kentucky Institutional Animal Care and Use Committee. 
2.1 Induction of Pancreatitis 
Five month old male mice on a C57BL/6 background weighing less than 40g (The 
Jackson Laboratory) were used for this study. Animals were housed in a temperature controlled 
room maintained at between 21-24°C, on a reverse light:dark 14:10 hour schedule. Control mice 
were fed rodent chow (Mouse Breeder Diet 8626) from Teklad (Madison, WI). AHF pancreatitis 
mice were fed a Lieber-DeCarli liquid diet from Test Diet (LD101A, Richmond, IN) and 
supplementary fat. The total fat content was about 57%. Alcohol was gradually added to the diet 
over a period of weeks from zero to 4%, 5%, and then 6%. AHF fed mice were maintained at 6% 
alcohol for the remainder of the study. Body weight was monitored weekly. 
2.2 Place Preference and Escape Testing  
Place preference and escape testing were conducted in a plastic box 22.8 cm x 15.2 cm x 
16.5 cm (9 in L x 6 in W x 6.5 in H) Great Choice Critter Tote (PetSmart) with dime sized air 
holes drilled in the top. A darkened divider with a door measuring 5.08 x 5.08 cm (2 x 2 in) was 
added to the box, dividing it into two equal chambers each measuring 11.4 x 7.6 x 8.3 cm (4.25 x 
6 x 6.5 in). Each place preference or escape test had a duration of 10 minutes. 
 
67 
 
2.2.1 Light/Dark Place Preference  
Test apparatus as in 2.2 was used for this test with one chamber of the box darkened, 
while the other chamber was well lit. In addition, free movement between the light and dark 
chambers was permitted through the 5.08 x 5.08 cm (2 x 2 in) opening. 
2.2.2 44°C/22°C Escape  
Test apparatus as in 2.2 was used for this test. One chamber of the test apparatus had a 
floor regulated to 44°C and was darkened. The other chamber had room temperature flooring at 
22°C±1°C with bright light. In addition, free movement between the light and dark chambers 
was permitted through the 5.08 x 5.08 cm (2 x 2 in) opening. Mice were added to the 44°C side 
of the box and grooming, transitions, rearing, and latency to rear were recorded. 
2.3 Smooth or Rough Mechanical Plate 
The test apparatus consisted of a clear Plexiglas box (11cm X 8cm X 8cm) placed upon 
either a smooth or roughly textured surface. Rearing exploratory activity, including frequency 
and duration, with or without a rough textured floor insert (the textured side of a polystyrene 
ceiling light panel diffuser (89091, Lowes.com), was monitored in real time and captured using 
custom software during 5 min tests.  
2.4 Plus Maze  
Testing on the plus maze was modified from that previously described and will be 
described here (Lyons et al., 2015). The elevated plus maze (Bioseb, Vitrolles, France) consists 
of four arms arranged in a cross-shaped design (length: 35 cm, width: 5 cm/each, height from 
floor: 51 cm). Two arms are enclosed on three sides by 15-cm high walls and the other two are 
not. All arms meet in a central area (5 cm × 5 cm) which allows animals to move freely 
throughout each zone of the maze. Mice were initially placed in the central area of the maze and 
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allowed to explore the maze for a period of 5 min. Mouse behaviors were recorded and analyzed 
for: (1) time spent in open arms, (2) number of transitions into the open and closed arms, and (3) 
number of head dips into the open arms, defined as the movement of the animals head from the 
closed arm to the open arm of the maze. In this test, the open arms represent a potentially 
threatening environment.  
2.5 Open Field 
Testing in the Open Field was completed as previously described in Lyons et al. (2015), 
and will be described here. Exploratory behaviors were measured using a Flexfield Animal 
Activity System (San Diego Instruments, San Diego, CA, USA). This apparatus consists of two 
Plexiglas chambers (40 × 40 × 36 cm) equipped with Photobeam Activity System (PAS) 
software coupled to a Compaq 486 computer (Hewlett Packard, Palo Alto, CA, USA). Each 
chamber contained infrared photobeam sensors with 16 beams on each axis (total of 32 beams) 
that are arranged 1.25 cm above the chamber floor. Obstruction of these photo beams constituted 
movements in the x - and y -planes. The x - and y -planes were further divided into a central and 
peripheral area. Another set of 16 beams is located 8 cm above the chamber floor to record 
movements along the z -axis measured i.e. rearing events and rearing duration (Zhang et al., 
2004). Data were collected in 5-min intervals for a total of 45 min to record: (1) number and 
duration of rearing events (2) active time vs. rest time, (3) overall distance traveled, (4) total 
beam breaks, and (5) time spent in the central verses peripheral areas of the chamber. 
2.6 Modified 44°C Hotplate Assay 
This procedure was performed as in Kline and Wiley (2008), and will be described here. 
In modified 44°C hotplate testing, mice are first placed on a 38°C hotplate for ten minutes in 
order to slowly pre-warm the animal’s feet. Thereafter the mice were moved to a 44°C hotplate  
 
69 
 
for a ten-minute testing period (Kline and Wiley, 2008). In this study, jumping events, rearing 
events, and latency to first jump were the dependent variables and were recorded using custom 
software.  
2.7 Drugs 
2.7.1 Mu-opioid Receptor Agonist  
Loperamide HCl (SIGMA-Aldrich, Milwaukee, WI) is a peripherally restricted, mu-
opioid receptor (MOR) agonist commonly used to treat diarrhea (Awouters et al., 1993). 
Loperamide HCl was suspended in a 20% solution of 2-hydroxypropyl-β-cyclodextrin (Sigma-
Aldrich, Milwaukee, WI) in saline and diluted to the proper dose concentration. Loperamide HCl 
injections were made intraperitoneally (i.p.) at 0.4, 0.6, 0.8, or 1.2 mg/kg and testing began at 60 
minutes after injection (Reichert et al., 2001, Everhart and Ruhl, 2009).  
2.7.2 TRPV4 antagonist 
HC067047 is a potent and selective TRPV4 antagonist (Tocris, San Diego, CA). 
Everaerts et al. (2010) have shown that this antagonist inhibits TRPV4 channel mediated 
responses to heat, arachadonic acid, and 4α-phorbol 12, 13-dihexanoate (4α-PDH). Injections 
were made intraperitoneally (i.p.) at 10 mg/kg, after which the mouse was returned to the home 
cage for at least 30 minutes. Testing began at 60 minutes after injection. This time frame was 
determined to be within the peak effective time period using the TRPV4 antagonist dose 
response curve generated by the authors of the Everaerts paper (Everaerts et al., 2010). 
2.8 Statistical Analysis 
The data were expressed as means±S.E. Comparisons among groups at different time 
points or different doses were performed with a two-way analysis of variance (ANOVA) 
followed by Tukey’s multiple comparisons post tests using SigmaPlot version 12.0 (Systat 
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Software, San Jose California, USA). Two-tailed t-tests were also used where appropriate. A 
p≤0.05 was considered significant.     
3. RESULTS    
3.1 Persistent Visceral Hypersensitivity Causes Stress Induced Analgesia.  
Testing of the 44°C/22°C escape response shows progressively increasing anxiety-like 
behavior from the eighth to tenth weeks as visceral hypersensitivity AHF CP model mice display 
significantly increased average transitions (see Figure 11) (week 8, control=46, AHF=64; week 
9, control=44, AHF=89; week 10, control=26, AHF=66; p=0.029, 0.031, 0.036 by two-way 
ANOVA and Tukey’s; n=6, n=6). Cumulative transitions become significant in the last three 
weeks of testing (Weeks 8-10) (p=0.029, 0.031, 0.036; by 2-way ANOVA and Tukey Test). 
Increased transitions between test chambers suggest stress has increased relative to untreated 
controls undergoing the same testing. 
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AHF mice displayed behavior indicative of chronic visceral hypersensitivity. 
Hypersensitivity is a stressor which could be causing the mice to increase exploratory behavior, 
with an intent to escape. In the seventh week average latency to 1st transition is increased 
significantly in the AHF animals indicating decreased locomotion in the AHF animals versus 
controls (see Figure 12) (control=1, AHF=3, p=0.031 by two-tailed t-test; n=6, n=6). This 
decreased initial activity is lost as transitions begin to increase significantly in the eighth week.  
 
3.2 Visceral hypersensitivity increases transitions in the Light/Dark Place Preference test 
(LD).   
In the LD, increased transitions between light and dark chambers indicate an increase in 
exploratory behavior (Bourin and Hascoet, 2003). AHF mice display increased exploratory 
behavior in week nine. In the last week of testing AHF mice show a significant increase in 
transition events relative to control mice (Figure 13) (by two-way ANOVA and Tukey’s Test).  
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3.3 Grooming behavior changes on the rough surface.  
Grooming is a displacement behavior, increased grooming typically indicates increased 
discomfort due to anxiety (van Gaalen and Steckler, 2000, Steimer, 2011). AHF mice show little 
change in grooming events from smooth to rough surface, regardless of treatment with either 
Loperamide or vehicle (Figure 14A). Normal chow control mice that are not experiencing 
visceral hypersensitivity display fewer grooming events from smooth to the rough surface. This 
decrease in grooming events is not significant, but is of note as grooming does not change in the 
AHF mice. In a similar manner, grooming latency increases significantly in saline or 
Loperamide-treated normal chow controls from smooth to rough surface testing (Figure 14B).  
There is no significant grooming latency increase in AHF mice from smooth to rough 
mechanical plate. AHF mouse Freeze Latency on the smooth surface increases significantly upon 
Loperamide treatment (Figure 14C). Freeze latency is not significantly different on the rough 
surface in Loperamide-treated AHF mice (Figure 14D). Control mouse latency to freeze remains 
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constant at 193±7 seconds while AHF mice decrease 49 seconds on the rough surface compared 
to the smooth surface (compare Figure 14C and 14D).  
 
 
 
 
 
 
3.4 AHF mice increased exploration in the Plus Maze.  
The number of closed arm entries is a measure of locomotion in the plus maze (Campos et al., 
2013). An increase in number of  closed arm entries on the elevated plus maze shows 
significantly increased exploration and locomotor activity in the AHF mice relative to controls 
(Figure 15A) (p=0.052, two-tailed t-test). The percentage of open arm head entries is considered 
a measure of anxiety-like behavior in the plus maze (Campos et al., 2013). AHF mice tested the 
Figure 14. Grooming behavior changes on the rough surface. (A) AHF mice show little 
change in grooming events from smooth to rough surface. (B) Grooming latency increases 
significantly only in normal chow controls during the transition from smooth to rough 
surface testing. AHF mice show an insignificant increase in grooming latency from the 
smooth to rough plate. (C) Loperamide treatment significantly increases AHF mouse 
freeze latency on the smooth surface. (D) Freeze latency on the rough mechanical plate 
decreases in AHF mice with little change seen in control mice.  (n=6, AHF all groups; 
n=7, All normal chow Control) 
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open arms with head entries significantly more than controls (Figure 15B) (p=0.043, two-tailed 
t-test).  
 
Figure 15. AHF mice increase exploration in the plus maze. (A) Significantly increased 
cumulative closed arm entries on the elevated plus maze indicate increased exploration and 
locomotor activity in the AHF mice. (B) Significantly increased open arm head entries indicate 
higher anxiety in the AHF mice.  
 
3.5 AHF mice display decreased escape behavior in the Open Field test.  
AHF mice display significantly decreased rearing events (Figure 16A and B) (p=0.0045 by two-
tailed t-test) and rearing duration (p=0.0045 by two-tailed t-test) in the open field test compared 
to vertical activity of the controls. Mice with anxiety-like behaviors display thigmotaxis, a state 
where the animal stays close to the walls of the test apparatus, avoiding the center (Simon et al., 
1994).                
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Figure 16. AHF mice display decreased escape behavior in the Open Field. (A) AHF mice 
display significantly decreased rearing events in the open field test. (p=0.0045 by two-tailed t-
test) (B) AHF rearing duration was significantly decreased in the open field test (p=0.0045 by 
two-tailed t-test). (C) AHF mice show a trend toward increased thigmotaxis in relation to control 
mice. 
 
3.6 AHF mice increased freeze events on the 44°C modified hotplate.  
A mouse freezes in response to a fear-provoking stimulus (McIlwain et al., 2001, Campos et al., 
2013). Freezing is defined as the absence of any movement, except for respiration, generally for 
a period of 5-10 seconds (Paylor et al., 1994). In Figure 17, the modified hotplate test provides a 
contextual stimuli. Vehicle treated control mice display more freeze events than in AHF mice. 
AHF mouse freeze events show no significant freezing change between Loperamide doses at 0, 
0.4, and 0.8 mg/kg. AHF mouse freeze events are significantly increased at a Loperamide dose 
of 1.2 mg/kg (p=0.025 by two-tailed t-test, n=7, n=6).  
 
Figure 17. AHF mice display increased freeze events on the modified hotplate. AHF mice 
freeze events increase significantly at a loperamide dose of 1.2 mg/kg (p=0.0022 by two-tailed t-
test). Control mice show little difference in freezing. 
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3.7 Low bodyweight increases thigmotaxis in AHF mice.  
By study week five the AHF treatment group split into a high and a low bodyweight group 
Figure 18A. AHF mice 1, 2, and 4 regularly consumed their lard supplement and at study 
endpoint weighed 45 g on average. AHF mice 3, 5, and 6 consumed less lard and at study 
endpoint weighed 34 g on average Figure 18B.  All AHF average combined mouse bodyweight 
was 40 g.  Chow fed control mice weighed on average 38 g at study endpoint. Mice with anxiety-
like behaviors display thigmotaxis, a state where the animal stays close to the walls of the open 
field test apparatus, avoiding the center (Simon et al., 1994). AHF mice with lower bodyweight 
explored the open field periphery more than did higher bodyweight mice Figure 18C.  
 
Figure 18. Low bodyweight AHF mice display increased thigmotaxis. Mice with lower 
bodyweight explored the open field periphery more than did the average to overweight 
bodyweight mice. This is an indication of increased anxiety in the low bodyweight mice. 
  
3.8 Grooming events decrease in AHF mice treated with HC067047.  
AHF mice in both vehicle and drug groups show a decrease in grooming events between the 
38°C and the 44°C modified hotplate (see Figure 19A). Control mice show little change in the 
number of grooming events between the 38°C and the 44°C modified hotplate. AHF mice show 
increases in freeze and rear events between the 38°C and the 44°C modified hotplate, while 
control mice increase in freeze events (Figures 19B and 19C). These changes are not significant 
by t-test. 
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4. DISCUSSION 
Significant differences between the AHF and control mice show that non-reflexive 
testing of AHF diet induced CP mice is valid. Non-reflexive testing allows for a more holistic 
view of the mouse study treatment groups, highlighting anxiety-like and fear-like behavior 
present in the animal. Anxiety interacts with pain report in the human clinical patient, therefore, 
it is absolutely necessary to include anxiety testing in a mouse model of human disease. A 
review of certain tests such as the plus maze and place preference tests in the battery results 
show that AHF mice show overall more anxiety-like behaviors, while displaying increased 
locomotion, both of which integrate with the increased exploration/escape responses seen in 
AHF mice. The AHF mice also show increased fear-like responses on the modified 44°C 
hotplate through increased Freeze events. In the open field AHF mice showed similar mobility 
Figure 19. HC067047 affects anxiety-
and fear-like behavior on the 44°C 
hotplate. (A) Grooming events decrease 
in AHF treated with HC 067047 on the 
44°C modified hotplate versus the 
38°C while grooming in control mice 
shows little change. (B & C) Both 
freezing and rearing events increase for 
AHF mice, while control mice show a 
definite increase in freeze events. 
  
 
78 
 
and decreased escape behaviors relative to controls. Testing with place preference, plus maze, 
open field, and the modified hotplate were done to better understand anxiety in CP. 
4.1 Place Preference 44°C/22°C Escape Task – Transitions  
Increased cumulative transitions on the 44°C/22°C Escape test by AHF mice indicate 
stress induced analgesia (SIA), likely due to greater starting hyperalgesia in the AHF group 
relative to controls. Escape testing forces mice to choose between an unpleasant and anxiety 
inducing brightly lit chamber, or a darkened 44°C hotplate chamber where the (heat induced) 
danger and attendant fear are clear and present (Rhudy and Meagher, 2000). Control mice choose 
to remain in the brightly lit chamber and experience anxiety-like behavior instead of the fear-like 
behavior (of heat damage) generated by the 44°C hotplate (Campos et al., 2013). AHF mice 
show signs of stress induced analgesia (SIA) which increases their latency to move out of the 
darkened chamber (off the 44°C plate).  
The increase in transitions, suggestive of SIA, is striking as AHF mice transition a total 
of 33 times more than controls in the final week, and spend more time in the 44°C dark chamber 
than do control mice. Increased transitions and SIA in the AHF CP model beginning in week 
eight suggests that the model progresses from normogesic and non-stressed to hyperalgesic and 
stressed, perhaps as human CP patients do. This suggests that the model is translatable to human 
CP patients as these patients experience anxiety (Madan et al., 2013), fear (Fitzsimmons et al., 
2005), and psychological components of the disease brought on by stress.  
4.2 Place Preference 44°C/22°C Escape Task – Latency to transition 
AHF mice display reluctance to transition between light and dark chambers in the 
seventh week likely due to increasing visceral hyperalgesia as CP begins. This behavior denotes 
an increase in anxiety-like behavior as the mice avoid entering the lit chamber, even though it 
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exposes them to algesic 44°C heat stimuli in the dark chamber. One interpretation of this 
behavior is that from an evolutionary standpoint, once a mouse is injured (visceral hyperalgesia 
begins) it is less able to escape from predators. Staying in the dark, even in the presence of 
algesic stimuli, would promote survival in an ill mouse. There is also the distinct possibility that 
SIA allowed the AHF mice to remain in the dark with the noxious heat longer before they had to 
remove themselves from the 44°C heat stimuli and expose themselves to light and the 
evolutionary anxiety posed by the danger of being seen by a predator. In support of this 
argument, significant SIA manifests as increased transitions occur in week 8, which correlates 
with increased von Frey mechanical hypersensitivity data from week 7 (see Chapter 2). 
4.3 Light/Dark Place Preference Test - Transitions  
AHF mice transition significantly more in the light/dark place preference test in week 
nine, indicating an increase in exploratory behavior due to the anxiolytic effects of stress induced 
analgesia. Increased stress on the mouse has been shown to trigger SIA, a form of endogenous 
analgesia, which can become conditioned to the test environment. The light/dark place 
preference test is typically considered an unpunished test (moving from lit chamber to darkened 
chamber includes no penalty). However, there is the possibility of contextual fear-like behavior 
induction here as the light/dark test apparatus used was also used for 44°C/22°C Escape testing, 
which does punish the mice when they attempt to seek the darkness as the darkened chamber 
floor is regulated to 44°C. Note that while both control and AHF animals were likely to 
experience stress upon placement in the test apparatus, the AHF mice entered testing with 
increased stress due to visceral hyperalgesia. AHF mouse visceral hyperalgesia stress is additive 
to that produced by testing. 
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4.4 Smooth or Rough Mechanical Surface - Grooming 
The transition from smooth to rough surface affects anxiety-like behavior (grooming) and 
fear-like behavior (freezing) differently in Loperamide treated control and AHF CP mice, due to 
AHF mice hyperalgesia. Note that saline treated control mice, which represent the average 
untreated mouse, show a significant decrease in grooming (anxiety-like behavior) from the 
smooth to the rough surface. Both saline and Loperamide treated groups of AHF CP mice 
meanwhile show no significant difference on the smooth to rough surface, presumably since 
mice with visceral hyperalgesia have activated endogenous opioids. The endogenous opioids of 
the AHF CP mice would activate the same mu opioid receptors that Loperamide uses in an 
attempt to inhibit constant visceral pain. If the receptor is already occupied, then Loperamide 
would not further affect hyperalgesia.  Also note that grooming latency increases significantly 
for both groups of control animals but not for AHF CP mice in the move from the smooth to the 
rough surface, indicating the anxiety-like behavior relieving action of Loperamide, but only in 
the control mice with intact, undamaged pancreas.  
4.5 Smooth or Rough Mechanical Surface - Freezing 
Freeze latency in Loperamide treated mice is significantly lower in AHF CP mice on the 
smooth surface. This latency decreases by about 16% (49 seconds) on the rough surface 
indicating that this continuous mechanical stimulation increases fear-like behaviors. Loperamide 
treated AHF mice on the rough plate also show a decrease in rearing (see Chapter 2) indicating 
decreased escape behaviors. 
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Table 7. AHF Mouse Fear-Like Behavior Rough Indication 
Rearing (Events and Duration) Decreased Decreased escape behaviors 
Freezing (Latency) Decreased Increased fear-like behaviors 
Table 7 summarizes AHF mouse rearing and freezing data from Figure 17. 
 
4.6 Plus Maze 
In Figure 15, the increase in closed arm entries as well as open arm head entries of AHF 
CP mice relative to controls are indicative of increased exploration and anxiety-like behavior due 
to the effects of chronic visceral hyperalgesia. Plus maze pain model testing generally shows 
decreased closed arm entries, however, AHF mice show increased exploratory drive, possibly 
due to the effects of stress induced analgesia. SIA, just like in continued motion of injured 
human marathoners, causes the mice to continue to move quickly through the closed arms, even 
though an injured mouse would be expected to attempt to locate a dark place safe from predators. 
Once located the injured mouse would be expected to stay in this darkened area which is 
provided here by the closed arms, as the closed arms are darker than the center or open arms. The 
AHF mice are interested in exploring the open arms but are reluctant to do so due to their chronic 
hyperalgesia-induced anxiety-like behavior because they would be less able to quickly return to 
the safety of the dark arms. 
4.7 Open Field Testing - Exploratory Behavior and Anxiety-like Behavior  
As shown in Figure 16, AHF mice display decreased exploratory behavior on the open 
field test caused by increased anxiety-like behavior. Rearing (Crawley, 1985) and rearing 
duration are escape behavior indicators. Anxiety can cause decreased rearing (Neubert et al., 
2007). Anxiety can also cause decreased rearing duration as anxiety-like behavior wins out over 
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escape behavior. A mouse, for instance, could be rearing when anxiety fueled innate predator 
avoidance behavior causes the mouse to drop out of the rear and into a more defensive position.  
4.8 Open Field – Thigmotaxis  
AHF mice in the low bodyweight group displayed increased anxiety-like behavior 
through thigmotaxis. Mice prefer dark, small, unexposed areas, likely due to evolutionary 
pressure leading to higher survival for mice that stayed hidden from the sight of predators 
(Campos et al., 2013). Anxious mice tend to spend more time exploring the periphery of the 
open field test (Simon et al., 1994). The low body weight AHF mice displayed greater stress than 
higher weight AHF mice, or control animals. Low bodyweight mice demonstrate thigmotaxis, 
the exploration of the periphery of the test chamber, due to increased stress. Less center time is 
an anxiety-like behavior. 
4.9 Modified 44°C Hotplate with Loperamide – Freeze  
As shown in Figure 17, freeze events are significantly increased in 1.2 mg/kg 
Loperamide treated AHF mice possibly due to contextual fear imbued in the hotplate setting. The 
hotplate setting can cause contextual fear-like behavior (Campos et al., 2013) and fear-like 
behavior is indicated when mice freeze. Conditioning of AHF mice by hotplate algesic stimuli 
causes fear-like behavior in AHF mice already stressed by visceral hyperalgesia. It is likely that 
“fear” of the hotplate algesic stimuli causes increased freezing in stressed AHF mice despite the 
analgesia typically provided by Loperamide. 
4.10 Modified 44°C Hotplate with HC067047 - Grooming 
AHF mice treated with HC067047, a TRPV4 antagonist, show decreased grooming 
events, indicating decreased anxiety-like behavior. Concurrently, both rearing (see Chapter 2) 
and freezing events increase suggesting that anxiety-like behavior is replaced with fear-like 
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behavior and exploration with intent to escape. The increase in rearing and freeze events may 
indicate that while HC067047 is an effective TRPV4 antagonist, it is less effective at inhibiting 
fear-related algesia behaviors experienced at 44°C (see Chapter 2). Except for increased freezing 
the control mice showed little to no shift in behavior suggesting that the HC067047 drug may 
have decreased algesic stimuli in the healthy controls. Control mouse increase in freezing could 
be attributed to contextual fear of the hotplate setting. 
5. SUMMARY 
Production of a dietary induced mouse model of AHF-induced CP without the use of 
harsh chemicals provides a more clinically translational model. A test battery including 
light/dark and 44°C/22°C place preference, plus maze, open field, and the modified hotplate can 
be used to better understand anxiety-like behaviors in a mouse model of chronic visceral pain. 
Testing in the CP model indicated that increased anxiety-like behavior develops after week 8, 
showing that non-reflexive testing is a valid indicator of chronic pain and anxiety. The AHF 
mice with CP display increased anxiety-like behaviors including increased exploration/escape 
responses and locomotion in the plus maze, and fear-like freezing behavior on the modified 44°C 
hotplate. In the open field test where mice explore spontaneously, AHF mice initially showed 
mobility and escape behaviors similar to controls, but continuation of the test promoted 
decreased escape behaviors. Thus, this study indicates AHF mice with CP have increased 
anxiety-like behavior, as do human patients who are diagnosed with CP pain, and thus provides a 
reasonable model to test pharmacological drugs to reduce anxiety accompanying chronic pain. 
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CHAPTER 4: Gerontological Considerations, Summary, and Conclusions 
1 INTRODUCTION 
 The research presented in this dissertation, based on the production of this AHF mouse 
model of CP, show how long-term overconsumption of alcohol and a high fat diet can influence 
health span through decreased pancreatic health over the long term. A mouse model of CP 
induced only by consumption of a liquid diet with added alcohol and high in fat was the first task 
and composes Specific Aim One. Histopathology and hypersensitive behaviors indicated the 
production of the AHF CP mouse model, which will be presented first. Characterization of 
anxiety-like behavior in the AHF CP mouse model using both reflexive and non-reflexive testing 
methods was the second Specific Aim task. Anxiety-like and fear-like behavior were 
characterized in the model. Specific Aim 2 will be presented following Specific Aim 1. 
This chapter provides a summary and conclusions of the research findings. One topic of 
the work is that consumption of the AHF diet in mice causes decreased pancreatic health 
manifesting as CP. In humans lifestyle changes can decrease the risk factors for damaging the 
pancreas through the AHF diet. Significantly decreasing or abstaining from alcohol, and eating a 
healthy diet reduce risk factors for CP development. Compression of morbidity is harder to 
obtain for a mouse or a human when consuming the AHF diet.  
Physiologic reserve tends to decrease in normative aging. Chronic physical and mental 
pain decrease reserves further, which can lead to increased mortality at a younger age. 
Maintenance of health is diminished in populations such as alcoholic pancreatitis sufferers due to 
overconsumption of alcohol, and consumption of high fat foods. Alcohol and high fat foods can 
be comforting and assist in an individual’s control of stress in their life (Gilman et al., 2008, 
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Tomiyama et al., 2011). Using alcohol and food to control mental anxiety would impact the 
physical body. 
The specific aims will be discussed one at a time, followed by a summary of the results, 
and finally limitations for each chapter.  Future research will then be discussed. The main 
findings of the work supporting the two experimental questions are summarized in Chapter 2 “A 
Mouse Model of CP Induced by an Alcohol and High Fat Diet”, and Chapter 3 “Anxiety-like and 
Fear-like Behaviors in a Mouse Chronic Pancreatitis Model”. See below for a synthesis of the 
main findings of the research that answer the two research questions of the study.  
2 SPECIFIC AIM 1: PRODUCE THE ALCOHOL AND HIGH FAT CHRONIC 
PANCREATITIS MOUSE MODEL 
 The first aim of the research was to produce a CP mouse model induced only by an 
alcohol and high fat diet. This mouse model was expected to show both histopathology and pain-
like behaviors indicative of CP. The AHF diet has been shown to reliably induce CP and pain-
like behavior in rats (McIlwrath and Westlund, 2015, Zhang et al., 2015). This particular CP 
model has not been produced in mice but would allow for work in transgenic mice. Mouse 
genetic modification techniques are much more reliable than those for rats.  
The modified Lieber-DeCarli diet was fed over a period of months during which AHF 
mice showed indications of increased hypersensitivity to algesic stimuli. AHF mouse pancreatic 
histopathology was also indicative of CP with increased fibrosis, atrophy, and diffuse nuclear 
material apparent. These histopathological indicators as well as hypersensitivity in the AHF mice 
indicate the presence of CP. Drugs were also tested to determine their effectiveness for relief of 
hypersensitivity in the AHF CP mouse model.  
 The study of CP in a non-chemical-induced mouse model is essential to understand the 
disease. The AHF diet induces the morbidity of CP in mice in a manner similar to the induction 
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of the morbidity of CP “process” in humans. The research data presented here, as well as the 
literature (Marmot, 2015), highlight the need for humans to make healthy lifestyle choices over 
time to maintain physiological reserve and health.  
2.1 Chapter 2 Results 
  The AHF only induction of CP in a mouse model is a reality and exhibits face validity as 
the model displaying both histopathology (physiological) and hyperalgesia (behavior) common 
to CP.  
Histopathology 
a. Histopathology conducted on the pancreas of AHF pancreatitis mice showed 
morphology common to CP: fibrosis, diffuse nuclear material, and poor cellular 
geometry. 
b. Percent fibrosis of pancreas in the AHF pancreatitis mice was significantly greater 
when compared to normal chow controls. 
Hyperalgesia  
c. AHF mice displayed mechanical hypersensitivity with a lower paw withdrawal 
threshold than controls on the von Frey test. 
d. AHF pancreatitis mice showed significantly increased numbers of rearing events on 
the rough surface and the 44°C modified hotplate. 
Drugs 
e. Loperamide increased PWT in AHF pancreatitis mice significantly nearer to control 
values and produced a dose-dependent decrease in rearing events of the AHF pancreatitis 
mouse on the modified 44°C hotplate.  
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f. Treatment of AHF mice with TRPV4 antagonist HC067047 significantly prolonged the 
first jump latency, and the number of jump events decreased, on the 44°C hotplate. 
2.2 Limitations of the Research 
 
Access to funding, and specialized resources, as well as a limited time-frame influenced the 
research. There was a limited time frame to complete production and characterization of the 
AHF CP model, consequently certain questions had to be shelved for future research. Patients 
with CP tend to be smokers, who over-consume alcohol, and may eat high calorie foods (Yadav 
and Lowenfels, 2013). Enhancing the AHF diet with smoking could create a mouse model that 
more fully recapitulates the clinical etiology of human CP. Smoking may drive increased 
progression of disease in the mouse model. This AHF diet with smoking is not at all common in 
the literature, though it appears to be the most clinically relevant model. Note that Kentucky has 
one of the highest smoking rates in the country at up to 27% (CDC, 2015a). Smoking resources 
were enquired about but would have had time requirements beyond those available. Funding for 
this research was not available.  
2.3 Future Research 
2.3.1 Blood Alcohol Concentration 
Blood alcohol concentration (BAC) is a measure of alcohol concentration in the blood. The BAC 
changes depending on how much and what type of alcohol has been consumed over a period of 
time (Cox et al., 1985, Fisher et al., 1987). Though blood samples were taken from the mice and 
processed into serum, a BAC alcohol analyzer was not available for testing samples. Future 
research should include BAC testing.  
Blood alcohol concentration was estimated using the BAC formula in Winek and Murphy 
(1984). See Appendix A for calculations. The estimated blood alcohol level of the AHF mice is 
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between 0.021 and 0.086 percent at any given time. The AHF mice consumed different amounts 
of alcohol-enriched liquid food each day over the course of the study. At the low end of the 
range (BAC=0.021) humans may exhibit slight impairment (NHTSA, 2005). A BAC of 0.086 
would result in a loss of balance and reaction time in humans (NHTSA, 2005). A BAC of 0.08 in 
a human is considered legally intoxicated (NHTSA, 2005). The AHF mice performed 
comparably to the control mice on the Open Field test, indicating no loss of locomotion (see 
chapter 3). AHF mice did not exhibit ataxia or other notable features on alcohol impairment 
possibly due to alcohol tolerance. 
2.3.2 The Alcohol and High Fat Chronic Pancreatitis Model with Smoking 
Patients with CP tend to be smokers, who over-consume alcohol, and may eat fatty foods 
(Yadav and Lowenfels, 2013). Enhancing the AHF diet with smoking could create a mouse 
model that mimics the etiology of human CP. An experimental timeline for such a study is 
proposed in Figure 20. Smoking may drive the faster progression of the AHF CP mouse model. 
This AHF diet with smoking is not at all common in the literature, though it appears to be the 
most clinically relevant model. Kentucky has one of the highest smoking rates in the country at 
up to 27% (CDC, 2015a). Resources to expose the AHF diet mice to smoking-like conditions 
were not immediately available. However, the experimental timeline is proposed. 
 
Figure 20. Alcohol and High Fat Chronic Pancreatitis Mouse Model with Smoking. Mouse 
cohorts acclimatize for one week then begin the Lieber-DeCarli liquid diet with added alcohol. 
Mice begin the diet at 0% alcohol and are stepped up gradually to the maintenance dose of 6%. 
Mice are exposed to “smoking” for fifteen weeks. 
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2.3.3 Rota-rod Physiological Reserve Testing 
While physiological reserve is a good concept for mechanistic explanation of the work, 
specific testing of physiological reserve would improve the research. Future research will include 
testing of a measure of physiological reserve at baseline and throughout the duration of the 
research.  
 Rota-rod testing is one option for testing physiological reserve change progression across 
the course of the research. In accordance with PR, AHF mice would be expected to lose function 
on the rota-rod at a higher rate than control mice. A decrease in PR brought on by harmful 
drinking and high fat consumption allows hazardous risk factor inflicted damage mechanisms to 
take root and damage the pancreas. The decrease in PR in the case of the AHF CP mice allows 
the progression of CP.  
3 SPECIFIC AIM 2: CHARACTERIZE ANXIETY-LIKE BEHAVIORS IN THE AHF CP 
MOUSE MODEL 
The second aim of the research was to characterize anxiety-like behaviors in the AHF CP 
mouse model using non-reflexive testing methods. Anxiety behavior characterization in mouse 
models of CP is sparse. Anxiety has been shown to be active as part of a disease intensifying 
stress-depression-anxiety axis (Takano et al., 1992, Krantz and McCeney, 2002, Leserman et al., 
2002, Roy-Byrne et al., 2008, Steimer, 2011). In humans, anxiety is often comorbid with pain 
and depression (Kroenke et al., 2013). The AHF CP mouse model was expected to show 
increased anxiety-like behaviors in non-reflexive testing relative to the controls. Increased 
anxiety-like and fear-like behaviors were detected in characterization of the AHF CP mouse 
model. Future work should include characterization of depression in the AHF CP mouse model 
because depression, anxiety, and chronic pain are interrelated in humans (Kroenke et al., 2013).  
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The modified Lieber-DeCarli diet was fed over a period of months during which AHF CP 
mice showed indications of increased anxiety-like behavior. AHF CP mice also showed fear-like 
behavior. HC067047 and Loperamide HCl drugs were tested to determine their effectiveness, or 
provide a positive control, for relief of hypersensitivity induced anxiety-like and fear-like 
behaviors in the AHF CP mouse model. 
AHF CP mouse model testing included both reflexive and non-reflexive testing. 
Reflexive testing does not require input from the brain. Mouse reflex action is spinal cord 
mediated. Laboratory animal drug testing has traditionally been concerned with relieving acute 
pain stimuli such as that seen on the hotplate test. Acute testing tends to focus on pain carried by 
the Aδ afferents, also known as “first pain”. First pain is immediate upon exposure to a painful 
stimulus. Descriptors of this pain in humans include “sharp” or “stabbing”. Aδ fiber myelination 
allows quick movement of the afferent pain signal to the brain. Aδ fibers conduct signals at a 
speed of (5-30 m/s) to the brain.  
Second pain is delayed pain felt after first pain subsides. Descriptors of this pain in 
humans include “dull” or “throbbing”. Second pain is carried by small unmyelinated C-fibers. 
The lack of myelination means slow movement of the pain signal to the brain. The C-fiber 
carries signals at a rate of (0.5-2 m/s) to the brain. 
 Chronic pain is a significant problem for patients in the clinic. Chronic pain in the clinic 
can be associated with prolonged activation of the C-nociceptors (Yeomans et al., 1996). Slow 
increases of nociceptive stimuli such as heat tend to replicate a type of pain seen in humans in 
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the clinic as it activates C-fiber nociceptors preferentially. Non-reflexive test measures require 
the ascending nociceptive stimulus to travel through the spinal cord, to the brainstem, and the 
cerebral cortex before motor action is taken. Significant behavioral differences between the AHF 
CP and control mice show that non-reflexive testing of AHF diet induced CP mice is valid. Non-
reflexive testing allows for a more holistic view of the mouse study treatment groups, 
highlighting anxiety-like and fear-like behaviors present in the animal. 
3.1 Chapter 3 Results 
Mice with AHF diet-induced CP show increased anxiety-like and fear-like behaviors. 
Anxiety-like Behavior 
a. A review of the plus maze and place preference tests show that AHF mice display 
overall more anxiety-like behavior, while displaying increased locomotion, both of which 
integrate with the increased exploration/escape responses seen in AHF mice. 
b. AHF mice display decreased escape behavior compared to control mice on the open 
field test while AHF mice in the low bodyweight group displayed increased anxiety-like 
behavior through thigmotaxis. 
Stress-induced analgesia (SIA)  
c. SIA allowed the AHF mice to remain in the 44°C dark longer before they had to 
remove themselves from the algesic stimuli.  
d. AHF mice transition significantly more in the light/dark place preference. 
Fear-like Behavior 
e. The AHF mice show increased fear-like responses on the modified 44°C hotplate 
through increased freeze events. 
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f. Freeze latency in Loperamide treated mice is significantly higher in AHF CP mice on 
the smooth surface. This latency decreases by 16% (49 seconds) on the rough surface 
indicating that this noxious mechanical stimulation increases fear-like behaviors. 
g. The increase in rearing and freeze events may indicate that while HC067047 is an 
effective TRPV4 antagonist, it is less effective at inhibiting fear-inducing algesia 
behaviors experienced at 44°C. 
3.2 Limitations of the Research 
 
Gerontological limitations center on the physiological, mental, and social complexity 
inherent in people in comparison to mice. Whereas people are physically and genetically 
heterogeneous, especially as they age, inbred laboratory mice are bred to be homogenous. People 
have much more complex lives and brains than laboratory mice. We have and can describe 
emotions, we can report pain, especially where the pain is, how intense it is, and the duration of 
pain. Humans also have cognitive complexity, a rich variety of social opportunities, and 
personalities that can affect health. People possess preconceived notions about aging and pain, 
and have the ability to make choices based on their perception of the situation. People can 
choose to go to a bar or eat high fat foods. Mice do not have free will under experimental 
conditions. They cannot choose their actions beyond a certain point. Human brains are more 
developed than mouse brains, especially in the areas of speech and thought. Mice obviously 
cannot talk like humans can. This makes studying certain factors like suicidal tendencies in mice 
impossible. There are many interactions here that cannot be easily studied in mice, if at all. 
Perception, for example, cannot be studied on a mouse model. Perception, however, plays a part 
in human pain. Animals can be influenced by a context such as familiar patterns in a chamber of 
a test apparatus but perception can’t be studied in a mouse. Pain is composed of at least two 
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parts, the physical and the psychological. So pain itself cannot actually be studied in an animal 
model, only pain-like behavior. 
 An important limitation in scientific research involving animals is the presence of a 
control group of animals for comparison to the experimental group. This control group, unlike 
the experimental group, does not experience the introduction of an experimental variable. In the 
research conducted in this dissertation there was a treatment group as well as a control group. 
The control group in an animal experiment helps the scientist determine if changes seen in the 
treatment group are due to treatment (the AHF diet here) or to normal changes taking place. 
Control mice in this research showed significantly less pancreatic tissue fibrosis than did AHF 
CP mice. In addition, AHF CP mice showed atrophy and irregular cellular architecture (Zhang et 
al., 2014), while control mice did not. The group receiving treatment showed marked pancreatic 
difference from the control group. This research data suggests that the AHF CP mouse pancreatic 
changes were due to the AHF diet. 
3.3 Future Research 
3.3.1 Cognitive Impairment 
AHF mice also did not appear cognitively impaired. It is of note however that mouse 
models of mild cognitive impairment (MCI) may not show locomotion changes (Pepeu, 2004). 
Cognitive impairment can manifest in a loss of weight in humans (Cronk et al., 2010). The AHF 
mouse group split into high and low bodyweight groups across the course of the research. 
Cognitive differences might have been apparent, if tested, especially in the low bodyweight AHF 
mice. Depression can be comorbid with cognitive impairment in humans (Bhalla et al., 2009). 
Future studies should include testing for cognitive impairment as well as comorbid 
depression. Cognitive impairment testing would include the Morris water maze (MWM). The 
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MWM detects cognitive impairment in mice tasked to locate a platform located within a pool of 
water. Mice that take longer to locate the platform, or do not stay in the quadrant the platform 
has always been in when the platform is removed on the last day, are likely cognitively impaired.  
3.3.2 Depression 
As anxiety, pain, and depression are interrelated, testing for depression-like behavior 
would have added another dimension to the research. The forced swim test, splash test, and tail 
suspension test can reveal the presence of depression in mice (Santarelli et al., 2003, Cryan and 
Holmes, 2005). The forced swim test involves allowing a mouse to swim in a cylinder full of 
water until it stops swimming. The presence of depression can be determined if mice fail to 
groom after sucrose solution is sprayed on their tail base.  In the tail suspension test, mice are 
suspended from their tail and observed.  
4 THE HEALTH SPAN, HOMEODYNAMIC SPACE, & AHF CHRONIC PANCREATITIS 
MICE 
Health span, the part of one’s life free from certain morbidities and disability, is 
decreased by factors such as overconsumption of alcohol and high fat foods. These risk factors 
are seen in the literature for humans who develop CP (Yadav and Lowenfels, 2013). The health 
span view is well suited to research concerning the production and characterization of an AHF 
CP mouse model. This research employed a health span view as AHF CP mice were compared to 
control mice. AHF CP mice have, through application of the 6% alcohol Lieber-DeCarli liquid 
diet and high fat lard supplementation seen a decrease in health in relation to control animals.  
The term homeostasis describes an attempt by the body to continually return to one set 
point, that remains the same, such as temperature, while homeodynamics covers the changes in 
this set-point as the body attempts to adjust to changes affecting its ability to adapt, its 
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homeodynamic space (Rattan, 2006). Chronic illness is indicative of a shrinkage and loss of 
homeodynamic space (Rattan, 2013, 2015). Homeodynamic space loss has been mitigated to 
some extent by the medical establishment. Medical treatments are available for those suffering 
from a variety of illnesses, and depending on the receptiveness and strength of the individual, 
can be quite effective against certain diseases. Many morbidities can be attenuated by exercise, 
good nutrition, stopping smoking, and keeping an eye on biomarkers of health such as blood 
pressure (Rowe and Kahn, 1998) p 17,41,78).  
5 JUSTIFICATION FOR THE RESEARCH 
The National Commission on Digestive Diseases (NCDD) under the umbrella of the 
National Institute of Diabetes and Digestion and Kidney Diseases (NIDDK), value the 
production of better animal models to further the study of alcoholic pancreatitis (Witt et al., 
2007). Pain-like behaviors in CP animal models are a crucial area of much needed research and 
have also been called for (Reed, 2014). The present study contributes to the study of CP in 
mouse models by providing a nontransgenic mouse model of alcoholic CP induced by diet alone, 
without the use of chemicals such as cerulein or dibutyltin (DBTC) commonly used to induce 
rodent models of pancreatitis. The association of pancreatitis pathology with anxiety has been 
understudied. Anxiety, like pain, is useful as a transient state but when anxiety is prolonged it is 
termed a disorder. Anxiety is often comorbid with pain and depression (Kroenke et al., 2013). 
Therefore, it is important to determine anxiety in mice with CP histology.  
6 FACE VALIDITY OF THE MODEL  
It is necessary to produce and use models that mirror etiologically determined risk factors 
as these are the most likely to properly predict the human patient’s response to treatments. 
Nontransgenic mouse models where pancreatitis is induced only by a combination of ad libitum 
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liquid food with added alcohol and lard supplementation are rare and study of anxiety-like 
behaviors has not been conducted in this mouse model. It is critical to produce and use models 
with construct validity in order to increase the predictive validity of drugs studied to treat CP. 
More than 50% of pharmacological treatments do not pass phases II and III testing due to lack of 
efficacy (Arrowsmith, 2011a, b). While a useful method for some studies, chemical injection to 
create disease may not capture with accuracy all that occurs in the body over time with natural 
onset chronic pancreatitis.  The AHF CP nontransgenic mouse model mimics disease induced by 
the risk factors of alcohol and high fat diet consumption found in humans with CP and provides 
construct and face validity, two factors important in predictive validity. 
7 PROS AND CONS OF CERULEIN OR DBTC PANCREATITIS INDUCTION 
Current rodent models of pancreatitis induced by chemical irritants such as cerulein or 
dibutyltin dichloride (DBTC) have proven fruitful for studies of acute pancreatitis. Cerulein 
injections expose the pancreas to supraphysiologic cholecystokinin (CCK) levels, which are not 
associated with the development of CP in humans, but do produce AP symptoms in mice (Reed, 
2014). Cerulein treatment, a common and reproducible method for induction of AP in mice, 
causes repeated damage to the pancreas as repeated injections are given, creating the cycle of 
damage to the pancreas like repeated human heavy alcohol use (Reed, 2014). DBTC treatment is 
a less used method as it is highly toxic, difficult to use in inexperienced hands, and like acute 
pancreatitis in patients it causes mortality in the process of disease development. Disease 
development occurs at a rate of about 33% in treated animals (Reed, 2014). In addition, DBTC 
does not cause CP in humans (Reed, 2014). The alcohol and high fat chronic pancreatitis mouse 
model more naturally recapitulates the etiology of alcoholic CP seen in humans.  
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8 SIMILARITY OF MOUSE RESEARCH TO ETIOLOGICAL RISK FACTORS OF 
ALCOHOLIC CHRONIC PANCREATITIS 
The AHF diet is similar to the overconsumption of alcohol (Irving et al., 2009, Yadav and 
Lowenfels, 2013) and high fat diet seen in humans that develop alcoholic chronic pancreatitis. 
Production of a mouse model of AHF-induced CP without surgery or injected chemicals 
provides a more etiology-based model. The AHF CP model exhibits construct validity in that CP 
is induced by a diet including high fat and alcohol. Human etiological risk factors for CP include 
alcohol abuse as heavy drinkers have 4X the risk of developing CP (Yadav et al., 2007a), while 
obesity, indicative of a high fat diet, increases the risk of developing CP by 2X (Sadr-Azodi et 
al., 2013). The AHF CP mouse regularly consumes alcohol (6%) and a high fat diet (57%).  
9 MODEL ENABLES FURTHER RESEARCH 
The induction of CP with the AHF diet follows the natural known etiology of induction 
in humans diagnosed with CP. In addition, the production of this model in mice allows for the 
future use of transgenic mice and drugs to further the study of alcoholic pancreatitis and 
associated conditions. This model also will allow for study of the effects of anxiety on 
pancreatitis histology.  
10 CONCLUSIONS 
10.1 Of Mice and Men 
The AHF diet model in mice is a useful model of human CP with many advantages for 
experimental studies. The AHF diet induces the morbidity of CP in mice likely in a similar 
manner as for the induction of the morbidity of CP “process” in humans. Like selected humans, 
older male mice that consume an AHF diet develop CP.  
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10.2 Healthy Dietary Choices in Two Populations  
Older male mice that do not consume an AHF diet appear healthy, with bright eyes and 
sleek fur. Control mice were in better condition than AHF mice like people who make lower fat 
food and moderate to no alcohol part of their lifestyle. Control mice, like a healthy population of 
people, may have lived natural lives to older old age in relatively good health while AHF mice, 
like an unhealthy population die young. 
10.3 Pain in Two Populations 
AHF mice displayed hypersensitivity not seen in control mice. Pain in humans 
significantly decreases quality of life (Fitzsimmons et al., 2005, Torrance et al., 2010). Control 
mice may have seen homeodynamic space shrinkage but AHF mice were in poor condition for a 
long time and appeared to have homeodynamic space shrinkage.  
10.4 Health in Two Populations 
Dietary choices that in humans can lead to the morbidity of CP such as overconsumption 
of alcohol & a high fat diet (Kushner et al., 2005, Irving et al., 2009, Sadr-Azodi et al., 2013, 
Yadav and Lowenfels, 2013), parallel those seen in alcohol and high fat mice that lead to 
induction of CP. Healthy dietary and lifestyle habits can decrease human morbidity (Maxmen, 
2012), and increase human population maintenance of homeodynamic space. Personal choices 
by humans about diet and alcohol use can affect individual and population health. Negative 
dietary choices can lead to loss of health in the population making these choices. Positive dietary 
choices can lead to maintenance of homeodynamic space. 
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APPENDIX A 
 
8 grams Liquid Diet with 6% EtOH 
BAC = (150/bodyweight)(% EtOH/50)(ounces consumed)(0.025) 
BAC= (150/0.0882 lbs)(6% EtOH/50)(0.01693 oz EtOH)(0.025) 
BAC= (1700)(0.12)(0.01693)(0.025) 
BAC= 0.086 
 
2 grams Liquid Diet with 6% EtOH 
BAC = (150/bodyweight)(% EtOH/50)(ounces consumed)(0.025) 
BAC= (150/0.0882 lbs)(6% EtOH/50)(0.0042 oz EtOH)(0.025) 
BAC= (1700)(0.12)(0.0042)(0.025) 
BAC = 0.021 
Figure 22. Calculating estimated blood alcohol concentration (BAC). Average weight of mice at study 
termination was 40 g which was converted here to pounds. The ethanol concentration was 6% in the 
prepared liquid diet. The average grams of alcohol consumed was converted to ounces. The average 
liquid food consumption was 8 grams/day, however, mice consumed as little as 2 grams/day. BAC range 
is calculated between 0.021 and 0.086 (Winek and Murphy, 1984). 
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